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CHAPTER 1.  GENERAL INTRODUCTION  
 
Thesis Organization 
This thesis is written utilizing the alternative format, including a general introduction 
to the research problem, a literature review, one peer-reviewed manuscript, two manuscripts 
submitted for publication, and a final chapter that summarizes the research and discusses 
ideas and recommendations for future research. References cited in each chapter are located 
immediately after each chapter.  
 
Statement of Problem and Research Summary  
Members of the genus Erysipelothrix are facultative anaerobic, gram-positive small 
rods that are ubiquitous in nature, found worldwide, and have been recognized as a cause of 
infection in animals and humans since the 1880’s (Wood and Henderson, 2006).  Strains 
have been isolated from many wild and domestic animal species including reptile, fish, 
amphibians, and humans; however, Erysipelothrix spp. is most economically important as 
the cause of swine erysipelas (Wood, 1984).  As one of the oldest diseases recognized by the 
swine industry, the isolation and diagnosis of swine erysipelas continues to hinder laboratory 
technicians and diagnosticians worldwide. This is evidenced by numerous protocols that 
have been described in the literature examining different culture and molecular methods 
aimed to isolate and identify Erysipelothrix. Diagnosis is complicated due to cultural 
characteristics, notably small colony size, and small numbers of organisms present in lesions 
(Fidalgo et al., 2000).  Isolation of the organism from contaminated specimens further 
compounds the issue and potential errors related to recognition have been reported (Dunbar 
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and Clarridge, III, 2000).  Chapter 3 describes the development and validation of a modified 
enrichment broth technique for the isolation of Erysipelothrix from experimentally and 
naturally infected swine (Bender et al., 2009).  This research indicates that an enrichment 
broth technique should be used by veterinary diagnostic laboratories.   
Data from the United States Department of Agriculture (USDA) continues to 
implicate swine erysipelas as one of the top ten reasons for swine condemnations at 
slaughter. Economic losses due to Erysipelothrix infection occur from increased numbers of 
acute deaths, treatments costs, vaccination costs, and slow growth of diseased pigs (Wood, 
1984).  Chapter 4 describes the adoption of an enrichment broth technique to investigate 
condemnations at slaughter suspected to be due to swine erysipelas. In addition, isolates 
obtained from condemned tissues were further characterized to evaluate the potential 
presence of new Erysipelothrix strains as this has not been investigated since the 1970’s.   
Chapter 5 describes research which aimed to identify and further characterize 
Erysipelothrix isolates from swine tissues and environments from six Midwestern United 
States swine sites. Research in this area has not been conducted on swine sites in the United 
States regarding swine erysipelas and associated tissue and environmental interaction also 
since the 1970’s (Wood, 1973; Wood, 1974; Wood and Packer, 1972).  Furthermore, 
Erysipelothrix spp. isolates currently used in vaccine strains utilized on the sites were 
compared to the recovered isolate and recently described molecular assays were utilized to 
further characterize all isolates (Ingebritson et al., 2010; Shen et al., 2010; To and Nagai, 
2007). 
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CHAPTER 2. LITERATURE REVIEW  
Introduction 
Swine erysipelas is a disease caused by the bacterium Erysipelothrix rhusiopathiae 
(Wood and Henderson, 2006).  The causative organism was first described as “bacillus of 
mouse septicemia” in 1876 by Koch (Brooke and Riley, 1999).  In 1882, Pasteur and 
Thuillier described a similar organism isolated from pigs with rouget, (Wood, 1999) and the 
first accurate description of the organism and disease it caused in swine was pusblished in 
the same year.  In the United States in 1885, Smith isolated E. rhusiopathiae from the 
kidney of a pig located in Utica, South Dakota and noted its resemblance to the organism 
previously described by Pasteur (Wood, 1984).  Due in part to its long history, the causative 
organism of swine erysipelas has undergone multiple name changes. Rosenbach was the first 
to distinguish three separate species of the organism, E. muriseptica, E. porci, and E. 
erysiploides (Wood, 1975).  Later it was recognized that these three species were nearly 
identical and they were all named E. indonesia in 1885 (Brooke and Riley, 1999).  In total, 
36 names have been documented for the organism to date. In 1966 all documented names 
were rejected and E. rhusiopathiae which was originally suggested in 1916 was accepted 
(Brooke and Riley, 1999).  Today, the genus Erysipelothrix is dividied into four separate 
species of Erysipelothrix, E. rhusiopathiae which includes serotypes 1a, 1b, 2, 4, 5, 6, 8, 9, 
11, 12, 15, 16, 17, 19, and N; E. tonsillarum containing serotypes 3, 7, 10, 14, 20, 22, and 
23, E. species strain 1 containing serotype 13 and E. species strain 2 containing serotype 18 
(Takahashi et al., 1987a; Takahashi et al., 1992).  There is some debate about the 
classification of E. species strain 1 and 2 and serotypes 13 and 18 are considered 
unclassified by some groups;(Takahashi et al., 1992) however, for the purpose of this paper 
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they are considered a species as previously described (Takeshi et al., 1999).  An additional 
species, E. inopinata has also been suggested however it’s role in swine has not been 
investigated (Verbarg et al., 2004). 
 
Morphology, Growth, and Biological Characteristics 
Members of the genus Erysipelothrix are non-motile, non-sporulating, non-acid fast 
slender gram-positive rods (Brooke and Riley, 1999; Wood, 1999; Wood, 2000).  The 
organism stains readily with ordinary dyes; however, is easily decolorized especially if the 
culture is old which has led to reports describing the organism as a gram-negative bacillus 
(Garcia-Restoy et al., 1991; Grieco and Sheldon, 1970; Wood, 1999).  The colony 
appearance of Erysipelothrix spp. can be described as either smooth or rough, with rough 
colonies being slightly larger with an irregular edge (Grieco and Sheldon, 1970; Wood, 
1999).  On agar media, colonies are clear, circular, and very small (0.1-0.5 mm in diameter) 
after 24 hrs, with increased size (0.5-1.5 mm in diameter) after 48 hrs (Carter, 1990; Wood, 
1999).  Most strains induce a narrow zone of partial hemolysis on blood agar media, usually 
with a greenish color. Rough colonies are not associated with hemolysis (Carter, 1990; 
Wood, 1999).  Erysipelothrix spp. is a facultative anaerobe and grows between 5°C and 
44°C, with optimal growth occurring between 30-37°C (Brooke and Riley, 1999; Carter, 
1990; SNEATH et al., 1951; Wood, 1999).  The organism favors an alkaline pH ranging 
from 7.2-7.6 (SNEATH et al., 1951).  The genus Erysipelothrix is generally inactive and 
does not react with catalase, oxidase, methyl red, and indole (Cottral GE, 1978).  The 
organism produces acid and hydrogen sulfide in triple-sugar iron agar (VICKERS and 
Bierer, 1958; White and Shuman, 1961; Wood, 1999).  Other gram-positive, non-sporolating 
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rod-shaped bacteria that can be confused with Erysipelothrix spp. include members of the 
genera Bronchothrix, Corynebacterium, Lactobacillus, Listeria, Kurthia, and Vagococcus 
(Bender et al., 2009; Brooke and Riley, 1999; Dunbar and Clarridge, 2000). 
 
Epidemiology 
Erysipelothrix spp. and infections caused by the organism occur worldwide and 
affect a wide variety of vertebrate and invertebrate species including but not limited to 
swine, sheep, cattle, horses, dogs, rodents, fresh and salt water fish, ticks, mites, flies, 
turkeys, chickens, and humans (Bricker and Saif, 1988; Grieco and Sheldon, 1970; Reboli 
and Farrar, 1989; Wood, 1999).  Swine erysipelas caused by E. rhusiopathiae is the disease 
of greatest prevalence and economic importance to the swine industry of North America, 
Europe, Asia, and Australia (Wood, 1984; Wood, 1999).  The domestic pig is the most 
important reservoir of E. rhusiopathiae and it is estimated that 30-50% of healthy appearing 
swine carry the organism in their tonsils and other lymphoid tissues (Stephenson and 
Berman, 1978).  Carriers can shed the organism in their feces, urine, saliva, and nasal 
secretions creating an important source of infection (Wang et al., 2010).  Previously both 
virulent and non-virulent serotypes were isolated from the tonsil (Takahashi et al., 1987c).  
In addition, another study showed that feces of apparently healthy animals contained 
virulent organisms (Wood, 1974).  Besides pigs, at least 30 species of wild birds and 50 
species of mammals are known to harbor the organism providing an extensive reservoir 
(Shuman, 1970).  The belief that E. rhusiopathiae can exist in the soil in the saprophytic 
form, living on dead and decaying material, has persisted for many years and early reports 
suggested the source of infection was the soil (Woodbine, 1950).  However, it was found 
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that the organism finds an unfavorable environment in the soil and dies rather quickly like 
most other non-sporulating organisms (Wood, 1973).  Interestingly, E. rhusiopathiae was 
found in the soil of swine pens and feces of apparently healthy swine and survived for a 
period of approximately 35 days under test conditions (Wood, 1974; Wood and Packer, 
1972).  The organism has also been isolated from pit slurry, and was reported to survive 2 to 
3 weeks in soil and on vegetation of pasture where the slurry was applied during the winter 
season (Chandler and Craven, 1980; Norrung et al., 1987).  Taken together, these 
observations suggest that carrier pigs are the primary reservoir of E. rhusiopathiae and that 
pen floors provide a temporary medium for transmission (Wood, 1984).  In meat, 
Erysipelothrix spp. persists for long periods despite chilling, freezing, curing, pickling, 
smoking, or salting (Grieco and Sheldon, 1970).  For these reasons it should come as no 
surprise that E. rhusiopathiae has been isolated from fresh fish, pork, and chicken 
designated for human consumption (Stenstrom et al., 1992; Ternstrom and Molin, 1987).   
 
Prevalence and Condemnations 
a. Historical trend of swine erysipelas outbreaks in the United States 
Minimal information exists related to morbidity and mortality associated with swine 
erysipelas in the United States. The number of Erysipelothrix spp. cases reported from 1931 
to 1959 is summarized in Table 1.  
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Table 1: Initial distribution of swine erysipelas in the United States.(Wood, 1984) 
Year Number of states 
affected 
1931 1 
1932 8 
1935 17 
1937 28 
1959 44 
 
Little data is available from 1959-1973, with the number of swine affected remaining 
fairly stable until 1973 (Wood, 1984).  During the National Hog Cholera Eradication 
Program from 1962 to 1978, 29% of investigated organs (mainly spleens) were found to 
contain Erysipelothrix spp. following submission to the Veterinary Services Laboratory, 
United States Department of Agriculture (USDA) (Harrington, Jr. and Ellis, 1972; 
Harrington, Jr. and Ellis, 1975).  Cyclical spikes in the number of swine erysipelas cases 
have been documented (Table 2). 
 
Table 2: Trends on Erysipelothrix spp. diagnosis based on case submission to the 
Veterinary Diagnostic Laboratory at Iowa State University (Opriessnig et al., 2004),(Wood, 
1984). 
   Year    1951 1957 1972-1982 2000 2001 2003-2009 
 Cases   194 53 11-48 18 66 8-31 
 
b. Trend in abattoir condemnations in the United States  
Condemnation data (number of carcasses condemned for acute swine erysipelas) is 
recorded by the USDA Meat and Poultry Inspection Service. Although this information only 
represents animals at slaughter and does not account for animals that die of swine erysipelas 
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prior to reaching market weight, it still remains a good source to track long term trends. 
Prior to 1940 cases of SE were combined with other systemic bacterial infections and 
categorized as “septicemia”; however, by the late 1940’s erysipelas was categorized 
separately (Wood, 1984).  The rate of erysipelas condemnations mirrored that of field cases 
and since the 1970’s the rate of erysipelas condemnation has remained fairly stable (Wood, 
1984).  Today, swine erysipelas is still a cause of condemnation at slaughter checks, ranking 
in the top ten (Table 3). 
 
Table 3. Top ten causes of swine condemnation, averages from 2003-2008 (Courtesy of 
Jackie Lenzy, FOIA-2008-000440). 
Classification Number of cases 
condemned 
Septicemia   14,838 
Pneumonia  12,618 
Abscess  12,192 
Peritonitis  11,208 
Icterus  7,170 
Injuries  6,923 
Contamination  6,068 
Miscellaneous   5,467 
Erysipelas  5,027 
Arthritis  3,719 
 
Pathogenesis and Clinical Signs of Disease 
Within 24 hrs of exposure to Erysipelothrix spp. a bacteremia usually develops 
leading to a systemic infection (Wood, 1999).  The pathogenesis of the early septicemic 
stage consists of changes involving capillaries and venules of most body organs, including 
synovial tissue (Schulz et al., 1975b; Schulz et al., 1977).  At 36 hrs after subcutaneous 
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inoculation, endothelial swelling and monocyte adherence to vascular walls occurs and 
evidence of hyaline thrombosis is usually seen (Schulz et al., 1975b).  This process is 
referred to as a shock-like generalized coagulopathy leading to fibrinous thrombosis, 
diapedesis, and invasion of vascular endothelium by bacteria and deposition of fibrin in 
perivascular tissues (Schulz et al., 1975b; Schulz et al., 1976b; Schulz et al., 1976a; Wood, 
1999).  Eventually, this process leads to connective-tissue activation in predisposed sites 
including joints, heart valves, and blood vessels (Schulz et al., 1976b).  Hemolysis and 
ischemic necrosis can occur in severe cases. One study reported a high incidence of 
encephalomalacia in acute experimental swine erysipelas and theorized that certain strains 
may damage endothelial cell barriers of the central nervous system (Drommer et al., 1970). 
Arthritis is the most important clinical manifestation of swine erysipleas from an economic 
standpoint, as the condition affects growth rate and is also responsible for significant losses 
of prime cuts at packing plants (Wood, 1999).  Studies have documented the chronic form of 
swine erysipelas beginning as early as 4-10 days after infection with E. rhusiopathiae 
(Schulz et al., 1977).  Severe fibrosis can subsequently lead to destruction of the articular 
cartilage within 5-8 months (Schulz et al., 1975a).  During this period of exudation and 
proliferation, the organism can be found in chondrocytes and may also present in synovial 
tissue and fluid (Franz et al., 1995).  While affected joints appear to become culture negative 
after 3-6 months, there is evidence that the organism does not entirely disappear from 
chronically infected joints (Franz et al., 1995; Schulz et al., 1976a; Schulz et al., 1977; 
Trautwein et al., 1976).  Clinically, three different forms of swine erysipelas can be 
differentiated: Acute, subacute and chronic (Table 4) (Grieco and Sheldon, 1970; Wood, 
1999). 
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Table 4: Clinical signs associated with different manifestations of erysipelas in pigs.  
Stage classification   Clinical signs 
Acute Sudden death  
General signs of septicemia 
Fever (40-42°C or greater)  
Withdrawal from the herd and lying down 
Avoidance of movement, stiff stilated gait, vocal when moving  
Partial or complete inappetence 
Cutaneous skin lesions resembling a “diamond” pattern  
Sow abortions  
Subacute Affected animals do not appear as sick as with the acute 
presentation 
Fever may be not be as high or persist as long 
Can remain unnoticed 
Chronic Lameness due to local arthritic changes 
Reduced growth rate  
Cardiac insuffiency due to proliferative endocarditis-like lesions is 
occasionally associated with sudden death  
 
 
Virulence Factors 
It has been shown that Erysipelothrix spp. isolates have considerable differences in 
virulence. In swine, 75-80% of isolates are consistently classified into E. rhusiopathiae 
serotypes 1a or 2 (Wood, 1999).  Early reports noted a correlation between serotype and 
clinical manifestation of disease. Previously, serotype 1a was isolated most commonly from 
cases of acute erysipelas, while serotype 2 was found to be more prevalent in cases of 
chronic erysipelas.(Wood, 1999) However, studies have contradicted these reports and 
demonstrated that all clinical conditions can be induced experimentally using a variety of 
serotypes (Kucsera, 1977; Wood et al., 1978).  Selected serotype 1a, 2, and 21 isolates were 
found to be highly virulent and capable of inducing generalized lesions or low in virulence 
associated with areas of localized irritation without further lesions (Hassanein et al., 2003).  
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The value of using serotype information to predict clinical manifestations is therefore 
debatable.  
There are a number of factors that are involved in the pathogenicity of the 
Erysipelothrix spp (Wang et al., 2010).  1) Neuraminidase: This enzyme is responsible for 
cleavage of sialic acids from sialo-glycoonjugates such as glycoproteins, glycolipids, and 
oligosaccharides and is expressed on host cells (Shimoji, 2000).  Removal of the sialic acid 
residues from these cells and glycoproteins disturbs host cell function and may also serve as 
bacterial nutrition (Schauer, 1985; Wang et al., 2010).  A significant correlation between the 
virulence of E. rhusiopathiae strains and the amount of neuraminidase produced has been 
demonstrated (Muller and Krasemann, 1976).  In experimentally infected rats which 
developed arteritis and thrombocytopenia in vitro adhesion of bacteria to aortic endothelial 
cells was inhibited by the addition of N-acetylneuramin-lactose, a substrate of bacterial 
neuraminidase demonstrating that neuraminidase plays an active and important role in 
bacterial attachment and invasion into host cells (Nakato et al., 1986; Nakato et al., 1987).  
2) Hyaluronidase: This spreading factor facilitates pathogen dissemination into tissues. The 
importance of hyaluronidase in the pathogenesis of disease associated with Listeria and 
Erysipelothrix spp. has been determined (Mann, 1969).  However, when virulence and 
hyaluronidase production of isolates obtained from joints of pigs with arthritis were 
investigated, no association between production of hyaluronidase and virulence was found 
(Norrung, 1970).  3) Capsular Antigens: Capsular antigen for Erysipelothrix spp. was first 
identified in 1986 and implicated in the pathogenesis of infection (Lachmann and Deicher, 
1986).  Tn916-generated mutants were constructed and it was determined that capsule-
deficient mutants were avirulent for mice (Shimoji et al., 1994).  Today, the heat-labile 
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capsule is considered a crucial factor in the pathogenesis of the infection. 4) Intracellular 
survival: The importance of intracellular survival of E. rhusiopathiae within phagocytes for 
the pathogenicity of the organism was already determined in 1969 (Timoney, 1969; 
Timoney, 1970).  A significant number of virulent organisms survived within macrophages 
from unimmunized mice and within polymorphonuclear leukocytes of pigs affected with 
erysipelas polyarthritis. Subsequent phagocytosis studies have shown that although 
enhanced phagocytosis was observed in the presence of immune serum, the virulent E. 
rhusiopathiae strains and its acapsular mutants were both ingested in the presence of 
immune serum (Shimoji et al., 1996).  However, the number of ingested bacteria was three-
to-fourfold greater for acapsular mutants demonstrating that the virulent strain resisted 
phagocytosis by macrophages (Shimoji et al., 1996).  5) Adhesion: In 1981 it was shown 
that E. rhusiopathiae isolated from swine affected with endocarditis or septicemia showed a 
higher degree of adherence to fresh heart valves of swine in organ culture than did strains 
isolated from other sources (Bratberg, 1981).  In vitro assays showed that strains of E. 
rhusiopathiae virulent for swine and mice adhered better to porcine kidney cell lines then 
avirulent strains (Takahashi et al., 1987b).  Adhesive surface proteins have been identified 
in E. rhusiopathiae and genes have been cloned and characterized showing that recombinant 
proteins have a high degree of binding to polystyrene, fibronectin, and Type I and IV 
collagens (Shimoji et al., 2003).  6) Surface protective antigens: Antibodies against cell 
surface components have been reported to play an important role in protection and a 64-66 
kDa cell surface antigen was found to have protective properties (Galan and Timoney, 
1990).  More recently, a gene encoding surface protective antigen (spa) A was cloned from 
E. rhusiopathiae strains 1a and 2(Makino et al., 1998; Shimoji et al., 1999) and the genetic 
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region responsible for protective immunity was determined (Imada et al., 1999; Shimoji et 
al., 1999).  In 1998, Southern and immunoblot techniques were used to classify E. 
rhusiopathiae isolates and serotypes 1a, 1b, 2, 5, 8, 9, 12, 15, 16, 17, and N were determined 
to possess the spa gene (Makino et al., 1998).  In 2007, the spa-related genes of all known 
E. rhusiopathiae strains and serotype 18 were determined (To and Nagai, 2007).  A total of 
three spa-related genes were identified and classified as follows: spaA identified in 
serotypes 1a, 1b, 2, 5, 8, 9, 12, 15, 16, 17, and N, spaB identified in serotypes 4, 6, 11, 19, 
and 21, and spaC identified in serotype 18.(To and Nagai, 2007) In a mouse cross-protection 
model it was then demonstrated that the three recombinant Spa proteins elicited complete 
protection against challenge with homologous strains but heterologous protection varied (To 
and Nagai, 2007).  Later, it was found that the spa type is not confined to a specific serotype 
group (Ingebritson et al., 2010).  Mice immunized with an E. rhusiopathiae serotype 2 SpaA 
strain and challenged with various E. rhusiopathiae isolates were completely protected 
against strains exhibiting the homologous strain; however, protection varied against strains 
possessing a heterologous spa or more than one spa type (Ingebritson et al., 2010).  A recent 
study further differentiated SpaB into SpaB1 (E. rhusiopathiae serotypes 4, 6, 8, 19, and 21) 
and SpaB2 (E. rhusiopathiae serotype 11) (Shen et al., 2010). 
 
Diagnosis 
Timely and accurate diagnosis of erysipelas is important as effective treatments are 
available. However, the disease needs to be distinguished from other differentials. 
Septicemia and sudden death can be seen with Salmonella choleraesuis, Actinobacillus suis, 
Actinbacillus pleuropneumoniae, and others and skin lesions resembling swine erysipelas 
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can also be observed with classical swine fever virus and porcine dermatitis and 
nephropathy syndrome. For diagnosis of Erysipelothrix spp. the following is available: 
bacterial isolation (direct or enriched), the mouse protection test, fluorescent antibody (FA) 
assays, immunohistochemistry (IHC) assay, and conventional and real-time PCR assays 
(Table 5).  
 
Table 5: Application of different diagnostic assays for identification of Erysipelothrix spp.  
Assay Required sample Turn-around time Treatment status of the 
animal  
Direct isolation Fresh tissue, fluid, 
or blood 
24-48 hrs Untreated 
Enrichment Fresh tissue, fluid, 
or blood 
48-72 hrs Treated or Untreated 
Mouse protection 
test 
Fresh tissue, fluid, 
or blood 
5-7 days  Untreated 
FA assay  24-48 hrs Untreated  
Fresh tissues 27 hrs Treated or untreated IHC 
Formalin-fixed, 
paraffin embedded 
tissues 
3 hrs Treated or untreated 
Conventional 
PCR 
Fresh tissue, fluids, 
or blood 
5 hrs Treated or untreated 
Real-time PCR Fresh tissue, fluids, 
or blood 
6 hrs Treated or untreated 
 
a. Isolation 
Direct culture: After 24 hrs and 48 hrs of incubation, Erysipelothrix spp. grows to 
form very small colonies, resides in low numbers, and can be difficult to isolate (Fidalgo et 
al., 2000).  
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1) Uncontaminated specimens: Specimens are placed into a beef or heart infusion broth 
containing 1% glucose. The broth is incubated aerobically at 35 to 37°C and subcultured 
onto tryptose agar containing 5% whole blood (Weaver, 1985).  Grinding or mincing of 
tissue samples and smearing them directly onto agar has been reported to increase isolation 
success (Carter, 1979).  Media is available from commercial vendors to isolate the organism 
from blood, as Erysipelothrix spp. has been shown to not be particularly fastidious (Carter, 
1990; Wang et al., 2010).  2) Contaminated specimens: In 1931, it was recommended to 
refrigerate broth inoculated with splenic pulp for 5 days to eliminate potential contaminants 
(Taylor, 1931).  In 1943, tryptose blood agar containing crystal violet and sodium azide to 
suppress contaminants was developed, which is commonly known as “Packer’s medium” 
(Packer, 1943).  Another method described in 1953 combined refrigeration of splenic pulp 
broth for 7-14 days followed by the use of Packer’s medium (Connell and Langford, 1953).  
Studies utilizing antibiotics to suppress contaminants followed in 1963 and sulfonamides 
incorporated into blood agar were found to increase the isolation rate of Erysipelothrix spp. 
from swine tonsils (ANUSZ, 1963).  At roughly the same time, neomycin and kanamycin 
were used (Fuzi, 1963).  In 1965, a method using enriched specimens (“Wood’s method”) 
was described: A liquid medium consisting of a tryptose broth, horse serum, and three 
different antibiotics (neomycin, kanamycin, and vancomycin) was used and subcultured 
following 48 hrs of incubation on Packer’s medium (Wood, 1965).  Modified blood-azide 
medium and Packer’s medium were compared and no significant difference in the number of 
isolations were observed; however, the incubation period was reduced in 78% of isolates 
grown on modified blood-azide media (Harrington, Jr. and Hulse, 1971).  Recently, the use 
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of Wood’s method was compared to the direct culture method and it was found that the 
Wood’s method is superior for Erysipelothrix spp. isolation success (Bender et al., 2009).   
b. Mouse protection test  
The mouse protection test is perhaps considered to be the best confirmatory test for 
the identification of Erysipelothrix (Weaver, 1985).  Erysipelothrix spp. growth in broth 
culture is administered to mice which in addition either get injected with or without 
antiserum produced in horses that were hyperimmunized. If the organism is in fact 
Erysipelothrix, the mice which did not receive the antiserum die within 5-6 days (Weaver, 
1985).  Using tonsils from healthy swine, the mouse protection test was compared with 
Wood’s method and no significant difference was identified (Stephenson and Berman, 
1978).    
c. Fluorescent antibody (FA) assay  
The first report on identification of Erysipelothrix by using a FA assay was 
documented in 1959 (Dacres and Groth, 1959).  In this assay, fluorescein isothiocyanate and 
a commercial anti-swine erysipelas serum from hyperimmunizing horses were used. As 
positive controls, cultures of Erysipelothrix from both swine and turkeys were utilized in 
addition to other bacterial agents which served as negative controls (Dacres and Groth, 
1959).  Direct and indirect FA assays have been used to identify Erysipelothrix, providing 
an alternative to the mouse protection test (Weaver, 1985).  However, in 1974 it was 
reported that the FA assay was not as sensitive as culture methods which resulted in 
decreased usage of this method (Brooke and Riley, 1999; Harrington, Jr. et al., 1974). 
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d. Immunohistochemical (IHC) assay   
An IHC assay was developed utilizing serotypes 1a, 1b, and 2 produced in rabbits. 
The resulting antiserum was pooled and applied to formalin-fixed, paraffin-embedded 
tissues and found to be highly sensitive and specific when compared to direct culture 
techniques especially in treated animals (Opriessnig et al., 2010).   
e. Polymerase chain reaction (PCR) assays 
Several PCR methods have been developed for the rapid detection of Erysipelothrix. 
The first conventional PCR assay capable of detecting Erysipelothrix DNA through the 
amplification of the 407-bp DNA fragment was described in 1994 (Makino et al., 1994).  
However, this PCR is genus specific and cannot differentiate between E. rhusiopathiae and 
E. tonsillarum. Similarly, in 1998 another genus specific conventional PCR assay which 
amplifies the 16S rRNA sequences of all four Erysipelothrix spp. was described (Shimoji et 
al., 1998).  An improved conventional differential PCR assay was described in 1999 which 
was based on a DNA sequence coding for the rRNA gene cluster including 16S, 23S, and 5S 
rRNA’s and the non-coding region. This PCR assay is able to distinguish between all four 
species of Erysipelothrix (Takeshi et al., 1999).  In 2006, the first conventional multiplex 
PCR assay was described to differentiate between E. rhusiopathiae and E. tonsillarum 
(Yamazaki, 2006).  Most recently a real-time multiplex PCR assay was described which 
detects and differentiates E. rhusiopathiae, E. tonsillarum, and E. sp. strain 2 (Pal et al., 
2009).   
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 Characterization 
a.Serotyping 
It was found that most strains of Erysipelothrix spp. contain two types of antigen; a 
heat labile protein which is species specific, and an acid stable polysaccharide antigen. 
These two antigens formed the basis for serotyping which is based upon a ring precipitation 
test using soluble antigens obtained by extraction with hot dilute acetic acid (Watts, 1940).  
The first identified serotypes were classified as A and B, and strains that did not react were 
called N (Watts, 1940).  Since 1973 serotypes of Erysipelothrix spp. have been identified by 
a number and the current range of serotypes includes 1-26 and N (Kucsera, 1973; Wood and 
Harrington, Jr., 1978).  Today, the standard method for serotyping utilizes a double agar-gel 
precipitation test with type-specific rabbit antisera and antigen recovered through the use of 
hot aqueous extraction (Kucsera, 1973; Wang et al., 2010).  
b. Ribotyping 
Genomic fingerprints can be created for species for which minimal information is 
available. The method used to create these genomic fingerprints is termed randomly 
amplified polymorphic DNA (RAPD) analysis. DNA that is amplified using this process can 
be used to determine the relatedness amongst bacterial species. In 2000 this method was 
applied to differentiate strains of Erysipelothrix spp. and 14 patterns in 81 strains of 
Erysipelothrix spp. were identified (Okatani et al., 2000).  The RAPD method was able to 
identify the genetic variation of strains of Erysipelothirx spp. and could rapidly and easily 
identify different strains of the same serotype (Okatani et al., 2000; Okatani et al., 2004).   
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c. Pulsed-field gel electrophoresis 
Among the current DNA-based typing methods, pulsed-field gel electrophoresis 
(PFGE) has been considered the gold standard (Olive and Bean, 1999).  Seventy strains of 
Erysipelothrix spp. were analyzed in 2001 using restricting enzyme SmaI and 90% of the 
strains had a distinct PFGE pattern (Okatani et al., 2001).  While some common bands were 
identified only a few strains showed identical patterns (Okatani et al., 2001).  PFGE is 
considered to be more sensitive than RFPD analysis and ribotyping making it an ideal tool 
for epidemiological studies (Olive and Bean, 1999),(Eriksson et al., 2009; Opriessnig et al., 
2004).   
d. Genotyping 
In 1992 the DNA relatedness among E. rhusiopathiae and E. tonsillarum strains 
belonging to several serotypes was examined. DNA-DNA hybridization experiments 
revealed two distinct groups, E. rhusiopathiae and E. tonsillarum (Takahashi et al., 1992). 
Serotype 13 and 18 isolates exhibited low levels of DNA relatedness with both species and 
have been classified as E. species strain 1 and 2 respectively, or simply as unnamed species 
(Takahashi et al., 1987a; Takahashi et al., 1992; Takahashi et al., 2008).  In 1998, the first 
PCR method able to distinguish E. rhusiopathiae without cross-reaction with E. tonsillarum 
was established (Shimoji et al., 1998).  Later, a PCR method capable of discriminating 
between E. rhusiopathiae and E. tonsillarum was described; however, required enrichment 
prior to DNA extraction (Yamazaki, 2006).  More recently multiplex PCR assays have been 
developed which can be used to identify and discriminate between all species of 
Erysipelothrix (Pal et al., 2009; Yamazaki, 2006).   
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e. Surface protective antigen (Spa) PCR  
Conventional PCRs have been described for detection of the spa gene. The gene 
encoding the protective Spa protein was first sequenced in 1998, and was subsequently 
named the SpaA (Makino et al., 1998).  Two additional types of spa-related genes were later 
identified within strains of E. rhusiopathiae and E.species strain 2 (To and Nagai, 2007).  In 
addition, recently a multiplex real-time PCR for determination of spaA, spaB1, spaB2, and 
spaC in the same reaction was described (Shen et al., 2010).  
 
Prevention and Biologics Development 
Since Erysipelothrix is considered ubiquitous in the environment, removal and 
regular disinfection of contaminated sources is important for control and transmission of the 
organism (Wood, 1975).   
a. Disinfection 
Erysipelothrix spp. can be inactivated by commonly available disinfectants (Conklin 
and Steele, 1979), and several commercially available home disinfectants have found to be 
highly effective; however, structurally complex equipment which contained organic matter 
was more difficult to disinfect especially without cleaning (Fidalgo et al., 2002).  Due to the 
inability of disinfectants to fully remove the organism from the environment, a multifaceted 
approach composed of sound husbandry, herd management, sanitation, and immunization 
has been recommended (Wood, 1999).   
b. Vaccination 
Immunization was first attempted by Pasteur in 1882 who noted the virulence of E. 
rhusiopathiae could be attenuated through serial passages in rabbits (Wood, 1984).  A 
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different method based on injecting virulent cultures followed by the injection of 
hyperimmune serum was developed in 1893 by Lorenz and was used in the United States 
from 1938 until1957 (Wood, 1984).  This was followed by development of attenuated or 
avirulent cultures which are still being used today, with the first avirulent vaccine being 
licensed in the United States in 1955 (Wood, 1984).  Attenuation of vaccines can be done by 
air-drying and passage through media containing acridine dyes (Kaden, 1983; Kaden et al., 
1985; Kaden and Glaner, 1982).  Bacterins consisting of strains of E. rhusiopathiae serotype 
2 were first used in the United States in 1953 (Wood, 1984).  No significant difference 
between avirulent live vaccines and bacterins were found under experimental conditions 
(Shuman, 1954).  Some of today’s attenuated vaccines contain E. rhusiopathiae  serotype 1a 
(Opriessnig et al., 2004).  Vaccination has offered protection for both pigs and turkeys 
(Groschup and Timoney, 1990).  Current vaccines have a variable duration of immunity. 
Depending on the type of strain and the animal species vaccinated, the duration of immunity 
varies between 6-12 months for both bacterins and avirulent vaccines (Swan and Lindsey, 
1998).  Vaccine failures can occur for various reasons and have been well documented in the 
United States, Japan, and Australia (Eamens et al., 2006b; Eamens et al., 2006a; Imada et 
al., 2004; Opriessnig et al., 2004).   
Much interest has been generated recently over potentially new vaccine candidates 
based on the Spa antigens. SpaA which is a common protective antigen has been regarded as 
the best choice for potential subunit and DNA vaccines (Imada et al., 1999; Shimoji et al., 
1999).  SpaA is only an example however, as various 64-66 kDa proteins have been purified 
from E. rhusiopathiae strains (Makino et al., 1998; Timoney and Groschup, 1993).  
Recently, Spa proteins have been cloned, sequenced, and advanced molecular assays to 
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classify all Spa proteins have been developed (Ingebritson et al., 2010; To and Nagai, 2007).  
With ongoing research an advancement of immunization products for Erysipelothrix is 
likely to occur.    
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Abstract  
The objective of this study was to compare the diagnostic performance of a direct 
isolation method for Erysipelothrix spp. with a broth-based enrichment technique. Samples 
were obtained from three sources: (1) experimentally inoculated pigs, (2) porcine tissue 
samples submitted to the Iowa State University Veterinary Diagnostic Laboratory, and (3) 
tissues from condemned carcasses at an abattoir. Culture plates from direct isolation and 
broth-based technique were evaluated for growth at 24 and 48 hrs. Results indicated that the 
broth enrichment method was markedly more sensitive for the isolation of Erysipelothrix 
spp. To the authors’ knowledge, this is the first comparison of direct culture and broth-based 
enrichment methods for the isolation of Erysipelothrix spp.  Interestingly, in several samples 
a Gram-positive bacterium with almost identical growth characteristics to Erysipelothrix 
spp. was detected and identified as a Vagococcus spp. through 16S rRNA gene sequencing. 
The results of this study indicate that the broth-based enrichment method should be used for 
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the isolation of Erysipelothrix spp. from clinical samples with a history suggestive of 
erysipelas and that Vagococcus spp. is potentially an important differential diagnosis.  
 
Summary of Short Communication  
Erysipelothrix spp. are facultatively anaerobic, Gram-positive small rods with 
worldwide distribution. Strains have been isolated from many domestic and wild species 
including reptiles, amphibians, fish, and humans. The genus Erysipelothrix contains four 
species: E. rhusiopathiae (serotypes 1a, 1b, 2, 4, 5, 6, 8, 9, 11, 12, 15, 16, 17, 19, 21, N), E. 
tonsillarium (serotypes 3, 7, 10, 14, 20, 22, 23), E. sp. strain 1 (serotype 13), and E. sp. 
strain 2 (serotype 18).16,17,18 
Erysipelothrix spp. is the causative agent of erysipelas in swine, sheep, fish, reptiles, 
and birds. Three clinical presentations of swine erysipelas are recognized. These include: 
acute infection commonly associated with serotype 1a, subacute infection, and chronic 
infection which are both typically associated with serotype 2. The additional serotypes (3-
26, N) have minimal clinical significance in swine.21 It is estimated that 30-50% of healthy 
pigs harbor E. rhusiopathiae in tonsils and lymphoid organs. These subclinically infected 
pigs are thought to be the source for acute erysipelas outbreaks due to shedding of the 
organism in urine, feces, saliva, and nasal secretions.12,21 
 Erysipelothrix spp. typically appears on artificial agar media as very small colonies 
after 24-48 hrs of incubation at 37°C.5,21 Specimen contamination can obscure colony 
growth on artificial media resulting in unrewarding and inconsistent isolation. To address 
potentially contaminated specimens, microbiology manuals describe the isolation of 
Erysipelothrix spp. using blood agar plates with sodium azide added to inhibit 
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contamination.2 In 1965, a liquid Erysipelothrix selective enrichment method was 
developed, commonly referred to as “Wood’s Erysipelothrix selective broth”. The 
enrichment method was found useful when attempting Erysipelothrix spp. isolation from 
feces and other contaminated material including intestinal lymphoid tissue, urine, nasal 
secretions, and decomposing animal tissue.20 In addition, selective agar media including 
sodium azide crystal violet (SACV) also known as “Packer’s medium”,13 nalidixic acid 
medium,1 and a modified blood azide agar15 have also been described to aid in the isolation 
of Erysipelothrix spp.4,5 A study reported no significant difference in isolation frequency 
between blood azide agar and SACV medium.8 
In a survey conducted in March 2008, all 10 Veterinary Diagnostic Laboratories 
(VDLs) surveyed in the Midwest were using direct culture as the standard method for 
isolation of Erysipelothrix spp. from case submissions suspected to be swine erysipelas 
(personal communication; Joann Kinyon, March 2008). The objective of this study was to 
compare the diagnostic sensitivity of the direct isolation method for Erysipelothrix spp. with 
a broth-based enrichment technique. 
The technique for sample preparation used in this investigation was based methods 
as previously described.3 Briefly, the outside of the tissue specimens were seared with a 
heated spatula to remove surface contaminants, the specimen was incised using a sterile 
scalpel blade and a sterile swab was inserted for collection of a tissue for culture. 
For the direct culture, the swabs were cultured on agar plates including trypticase soy 
agar containing 5% sheep blood (BA)c and colistin-nalidixic acid agar containing 5% sheep 
blood (CNA)a. Plates were incubated aerobically at 35ºC and examined at 24 and 48 hr post-
inoculation.3,6 Suspect colonies with the characteristic appearance similar to Erysipelothrix 
35 
 
 
spp. were subcultured on BA, incubated for 24 hr, and then biochemically confirmed using 
standard laboratory methods.16,21 Isolates confirmed as Erysipelothrix spp. were saved in 
BHI broth containing 50% glycerola and frozen at -80ºC for future evaluation. 
The Erysipelothrix spp. selective broth base was prepared as described and stored at 
5° C for a maximum of two weeks prior to use.20 The Erysipelothrix spp. selective medium, 
sodium azide crystal violet agar (SACV), was prepared as previously described.13 
Tissue specimens were homogenized using a stomacherd and 300 µl of resulting 
liquid tissue homogenate supernatant was added to a tube containing 3 ml of Erysipelothrix 
spp. selective broth. Incubation was conducted at 35º C for 24 to 48 hrs. At both time points, 
a 100 µl subculture from the Erysipelothrix spp. selective broth was made onto a BA plate, a 
CNA plate, and a SACV plate. Inoculated plates were incubated at 35ºC and observed at 24, 
48, and 72 hr for colonies characteristic of Erysipelothrix spp. Suspect colonies were 
subcultured on a BA plate, incubated for 24 hr, and then biochemically confirmed using 
standard laboratory methods.16,21 Erysipelothrix spp. serotyping was performed as previously 
described.23 Homologous positive controls were used with each test. Reactions were 
recorded after 24 hr.22 Gram stain, cell morphology, motility, oxidase and catalase activity, 
and H2S production on triple sugar iron agar (TSI) medium were used to confirm 
Erysipelothrix spp.16 
Data obtained from isolation attempts using different laboratory media and tissue 
comparison was assessed to detect statistical differences between direct and enrichment 
culture methods. A two-sample test (t-test) on the proportions utilizing the R version 2.7.2i 
statistical package was used. A P < 0.05 was considered significant.  
The experimental protocol was approved by the Iowa State University Institutional 
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Animal Care and Use Committee. Thirty-two, 2-week-old, conventional pigs were 
purchased from an isolated herd free of major swine pathogens including swine influenza 
virus, porcine reproductive and respiratory syndrome virus, and Mycoplasma 
hyopneumoniae. E. rhusiopathiae vaccination was not used in the breeding stock on the 
source farm. Upon arrival at the research facility, serum samples were collected and tested 
by an in-house ELISA (Courtesy Dr. J. Huchoppa) for the presence of anti-Erysipelothrix 
spp. antibodies and all pigs were found to be negative. The pigs were randomized by weight 
and divided into 8 groups of 2 to 6 pigs in each group (Table 1). Each group was housed in a 
separate room with identical dimensions, feed/water delivery system, and environmental 
controls. Pigs were monitored and allowed to acclimate prior to inoculation (day 0) for 15 
days. At inoculation the pigs were four weeks old. 
Erysipelothrix spp. strains used for inoculation (Table 1) were selected based on their 
importance for the U.S. swine industry: serotypes 2 (41.2%), 1a (21.1%), 1b (15.1%), and 5 
(9%) historically are the most common strains isolated from pigs in the U.S.23 E. 
tonsillarium (serotype 10) has been noted to cause clinical erysipelas in swine when 
inoculated by the intravenous route.22 E. sp. strain 1 (serotype 13) and E. sp. strain 2 
(serotype 18) were chosen in order to have representative serotypes from all described 
species of Erysipelothrix. The inocula were prepared in brain heart infusion (BHI) brotha 
supplemented with 5% fetal bovine serum (FBS)b and plated on brain heart infusion agara 
containing 5% FBS. Pre-trial standard plate counts were performed to determine log phase 
growth within 30 to 60 min after harvest and to estimate bacterial concentrations which were 
subsequently adjusted to log107 colony forming units (CFU)/ ml. Purity of the inocula was 
assured by culture and identification by standard methods.16  The pigs were inoculated using 
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3 routes. Each pig received 2 ml of the respective inoculum intramuscularly into the right 
neck, 2 ml intravenously in the left ear vein, and 0.1 ml intradermally in the left flank. One 
day post-inoculation (DPI), selected pigs (Table 1) were treated with 1.5 ml penicillinb 
(intramuscular into the right neck) in order to evaluate treatment effect on isolation success. 
At necropsy, tissues including tonsil, lung, heart, kidney, spleen, liver, skin, and blood were 
collected. Fresh tissues were collected aseptically and cultured immediately. Representative 
samples from each pig were stored in sterile specimen bags and frozen at -80ºC for future 
evaluation by enrichment.  
Field samples from pigs submitted to the ISU-VDL with a history suggestive of 
swine erysipelas such as acute septicemia (fever, lethargy, and decreased feed intake), 
rhomboid skin lesions, or chronic changes (swollen joints, lameness) suggestive of 
erysipelas were included in the investigation. In addition, tissue specimens including lesions 
suggestive of erysipelas resulting in carcass condemnations were collected by the veterinary 
inspector-in-charge at a regional abattoir. Tissues from the harvest facility were collected, 
placed into individual specimen bags, labeled, and then frozen at -20ºC prior to transfer to 
the laboratory. All tissues collected from field samples and abattoir condemnation were 
placed into individual specimen bags and stored at -80°C for direct enrichment. 
Table 2 summarizes the positive isolation results categorized by plate media. Using 
direct culture, there was no significant (P = 0.07) difference between the recovery of 
Erysipelothrix spp. from BA (35/466; 8%) or CNA (38/466; 8%). There was no significant 
difference (P = 0.71) in the total number of isolations when CNA media was added to the 
enrichment method protocol. Both CNA and SACV resulted in 360/498 (72%) tissue 
specimens being positive which was significantly (P < 0.05) higher compared to positive 
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isolations from BA plates (24/498; 4.8%). Although the use of CNA plate was not 
previously described in the enrichment method, this media was included to see if it could 
increase the speed of isolation. When CNA media was included, Erysipelothrix spp. was 
isolated in many cases as early as 12 hrs post-inoculation from the Erysipelothrix selective 
broth and by 24 hrs in every positive isolation case regardless of the tissue sample. Previous 
literature has described the growth of Erysipelothrix spp. on SACV medium taking as long 
as 48 hrs.8 In addition, CNA medium is commercially produced and readily available. The 
addition of the CNA medium allowed for faster isolation and diagnosis of swine erysipelas; 
however, it did not increase the sensitivity of the enrichment method.  
It is common for diagnostic laboratories to receive tissues from animals that have 
been previously treated with antibiotics.  The isolation success for the different tissues using 
direct or enrichment culture methods in treated and non-treated pigs is summarized in Table 
3. For all tissue samples (from treated and non-treated pigs) direct culture resulted in 14/96 
(15%) positive isolations of Erysipelothrix spp.  The direct culture method for all tissue 
samples (treated and non-treated) resulted in 14/96 positive for Erysipelothrix spp. isolation. 
Using enrichment culture, 51/96 (51%) of the tissue samples were positive for 
Erysipelothrix spp. Enrichment culture resulted in more positive isolation results for tissue 
samples from both the treated and untreated pig groups, and the isolation rate was 
particularly improved in the treated group.  Interestingly, 13/36 (36%) of the tissues 
obtained from experimentally inoculated pigs that were also treated with antibiotics were 
positive using enrichment culture. This may indicate that although antibiotics alleviate 
clinical signs, the organism is incompletely cleared from the body. In comparison, when 
using the direct method, Erysipelothrix spp. isolation was not successful (0/36) on any of the 
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tissues from the experimentally inoculated and treated pigs.  In addition, the choice of tissue 
to culture has minimal effect when using enrichment methods; however the use of spleen 
tissue resulted in slightly more positive isolations. Recovered isolates were identical to the 
inoculum administered to the pigs based on serotyping. E. sp. strain 1 was not cultured from 
any specimens using either direct or enriched culture. These findings may indicate that the 
pig is not the ideal host for E. sp. strain 1. Non-inoculated control animals were negative for 
Erysipelothrix spp. by both culture methods (data not shown).   
Field sample culture results are summarized in Table 4. A total of 193 tissue 
specimens from 89 individual pigs were submitted for culture. Erysipelothrix spp. was 
isolated from 16/193 (8%) of the submitted tissues by direct culture and from 163/193 
(84%) of the submitted pigs by the enrichment culture method which was significant (P < 
0.05) improvement in isolation rate. Increased sensitivity through enriched culture is a great 
benefit for veterinarians and producers who expect an accurate diagnosis when submitting 
specimens to a VDL. In addition, successful isolation allows for antimicrobial susceptibility 
profiles to be conducted, availability of isolates for autogenous vaccine production, and 
further characterization through serotyping and pulsed-field gel electrophoresis. These 
options are not available when only PCR diagnostics are utilized. 
Table 4 also summarizes the results obtained with direct and enrichment culture 
methods on tissue specimens that were condemned and collected at the abattoir. By the 
direct method, 8/177 (5%) of the tissues were classified as positive. In comparison, 137/177 
(77%) of cases were confirmed as positive by enrichment culture. Kidney was the tissue 
sample where Erysipelothrix spp. was isolated most frequently by direct culture and skin 
was the tissue most commonly positive by the enrichment culture method. The culture 
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results from the condemned pig tissues provided the veterinary inspector-in-charge at the 
abattoir with diagnostic evidence that carcasses condemned for swine erysipelas are 
frequently harboring Erysipelothrix spp. and provided producers a documented reason for 
the condemnations so they could use that information to implement appropriate prevention 
and control strategies. 
For further identification, the 16S ribosomal RNA (rRNA) gene was amplified, 
sequenced, and analyzed as described.7 Amplified products were purified with a QIAquick 
PCR Purification kitf and sequenced bi-directionally at the DNA Sequencing and Synthesis 
Facility at Iowa State University, Ames, IA, using the BigDye terminator chemistrye. The 
forward and reverse sequences were assembled into a consensus sequence and edited with a 
softwareh. Finally, the consensus 16S rRNA sequence was compared with those available in 
the GenBankg using the Basic Local Alignment Search Tool (BLAST) to find the most likely 
match.7 All but 16 isolates were identified as Erysipelothrix spp. using previously described 
laboratory methods.16 Twelve out of 16 of the isolates were confirmed to be E. rhusiopathiae 
by 16S rRNA PCR. Interestingly, 16S rRNA PCR identified the other 4 isolates (4/16) as 
Vagococcus spp. Vagococcus spp. appeared at 12-18 hr on CNA as small, transparent 
colonies with weak alpha or no hemolytic pattern very similar to Erysipelothrix spp. Upon 
Gram staining, the organism was Gram-positive and appeared as coccobacilli or as short 
rods. Biochemically, Vagococcus spp. was non-motile, catalase-negative, and produced 
hydrogen sulfide gas on TSI medium similar to Erysipelothrix spp. Vagococcus spp. 
however, produced a greater amount of hydrogen sulfide that is visible throughout the entire 
media, not just along the stab line. Vagococcus spp. was identified in tissues from three 
separate field cases. In all three cases, Vagococcus spp. growth was identified using the 
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enrichment method followed by subculture on CNA plates. In addition, Vagococcus spp. 
was isolated from a kidney specimen obtained from a harvest facility and was present on 
both CNA and SACV media using the enrichment method. While the significance of 
Vagococcus spp. has yet to be determined in swine, it has been described as an emerging 
disease of rainbow trout,14 seal and harbor porpoise,9 and has been isolated from a swine 
manure storage pit10 and pigs19. Additionally, Vagococcus spp. needs to be considered as a 
potential rule out or contaminant that is not inhibited by the enrichment method. 
Erysipelothrix spp. has been an important bacterial pathogen in the swine industry 
for over 100 years, and swine erysipelas continues to be one of the leading causes of swine 
carcass condemnations at harvest worldwide. Methods for accurate diagnosis and applicable 
treatment are becoming increasingly important. Diagnostic assays continue to be improved 
with advancements in PCR technology; however, these tests are not readily available in all 
VDLs. Historically, the ISU-VDL has not conducted both direct culture and broth-based 
enrichment methods for isolation of Erysipelothrix spp. from suspect swine erysipelas cases. 
In several of these cases, Erysipelothrix spp. was not routinely isolated in spite of clinical 
signs and lesions consistent with systemic bacterial infection.  Adoption of the enrichment 
method has substantially improved the quality of diagnostic capabilities for the ISU-VDL. 
Unlike with PCR, the availability of the isolates allows the laboratory to conduct 
antimicrobial sensitivities and further characterization of the isolates and provide them to 
clients for potential use of the isolates in autogenous vaccines if desired. 
 
 
 
42 
 
 
Acknowledgements 
Funding for this study was provided by Pork Check Off Dollars from the National 
Pork Board, the Iowa Livestock Health Advisory Council, and Schering-Plough Animal 
Health. The authors thank Dr. Howard Lindaman for assistance procuring samples, Dr. 
Abby Patterson for critical review of the manuscript, and the ISU-VDL Bacteriology section 
for assistance with the laboratory work. 
 
Sources and Manufacturers 
a
 Becton Dickinson, Sparks, MD. 
b
 Sigma-Aldrich, St. Louis, MO. 
c
 Thermo Fischer Scientific Remel products, Lenexa, KS. 
d
 Seward, Bohemia, NY. 
e
 Applied Biosystems, Foster City, CA. 
f
 Qiagen, Valencia, CA. 
g
 http://blast.ncbi.nlm.nih.gov 
hDNASTAR, Madison, WI. 
i
 R Foundation for Statistical Computing, Vienna, Austria 
 
Reference List  
1. Beerens H, Tahon-Castel MM: 1966, A nalidixic acid-medium for isolation of 
Streptococcus D pneumoniae Listeria and Erysipelothrix. Annales de l’Institut Pasteur 
111:90-93. 
43 
 
 
2. Carter GR: 1979, Listeria and Erysipelothrix. In: Diagnostic procedures in veterinary 
bacteriology and mycology, 3rd: pp. 194-195. Charles C. Thomas, Springfield, IL. 
3. Carter GR: 1990, Erysipelothrix rhusiopathiae. In: Diagnostic procedures in veterinary 
microbiology and mycology, Cole JR, 5th: pp. 195-196. Academic Press, Springfield, 
IL. 
4. Fidalgo SG, Riley TV: 2004, Detection of Erysipelothrix rhusiopathiae in clinical and 
environmental samples. Methods Mol Biol 268:199-205. 
5. Fidalgo SG, Wang Q, Riley TV: 2000, Comparison of methods for detection of 
Erysipelothrix spp. and their distribution in some Australian seafoods. Appl Environ 
Microbiol 66:2066-2070. 
6. Forbes BA, Sahm DS, Weissfield AS: 7 A.D., Nonbranching, Catalase-negative, Gram-
positive bacilli. In: Bailey & Scott’s diagnostic microbiology, 12th: pp. 665-666. 
7. Hall L, Doerr KA, Wohlfiel SL, Roberts GD: 2003, Evaluation of the MicroSeq system 
for identification of mycobacteria by 16S ribosomal DNA sequencing and its 
integration into a routine clinical mycobacteriology laboratory. J Clin Microbiol 
41:1447-1453. 
8. Harrington R, Jr., Hulse DC: 1971, Comparison of two plating media for the isolation of 
Erysipelothrix rhusiopathiae from enrichment broth culture. Appl Microbiol 22:141-
142. 
9. Hoyles L, Lawson P, Foster G, et al.: 2005, Vagococcus fessus sp. nov., isolated from a 
seal and harbour porpoise. Int J Syst Evol Microbiol 50:1151-1154. 
10. Lawson PA, Falsen E, Cotta MA, Whitehead TR: 2007, Vagococcus elongatus sp. nov., 
isolated from a swine-manure storage pit. Int J Syst Evol Microbiol 57:751-754. 
44 
 
 
11. Mansi W: 1958, Slide gel diffusion precipitin test. Nature 181:1289-1290. 
12. Opriessnig T, Hoffman LJ, Harris DL, et al.: 2004, Erysipelothrix rhusiopathiae: genetic 
characterization of midwest US isolates and live commercial vaccines using pulsed-
field gel electrophoresis. J Vet Diagn Invest 16:101-107. 
13. Packer RA: 1943, The use of sodium azide (NaN3) and crystal violet in a selective 
medium for streptococci and Erysipelothrix rhusiopathiae. J Appl Bacteriol 46:343-
349. 
14. Ruiz-Zarzuela I, de Blas I, Girones O, et al.: 2005, Isolation of Vagococcus 
salmoninarum in rainbow trout, Oncorhynchus mykiss (Walbaum), broodstocks: 
Characterization of the pathogen. Vet Res Com 29:553-562. 
15. Takahashi T, Fujisawa T, Benno Y, et al.: 1987, Erysipelothrix-tonsillarum sp-nov 
isolated from tonsils of apparently healthy pigs. Int J Syst Bacteriol 37:166-168. 
16. Takahashi T, Fujisawa T, Tamura Y, et al.: 1992, DNA relatedness among 
Erysipelothrix rhusiopathiae strains representing all twenty-three serovars and 
Erysipelothrix tonsillarum. Int J Syst Bacteriol 42:469-473. 
17. Takahashi T, Sawada T, Muramatsu M, et al.: 1987, Serotype, antimicrobial 
susceptibility, and pathogenicity of Erysipelothrix rhusiopathiae isolates from tonsils 
of apparently healthy slaughter pigs. J Clin Microbiol 25:536-539. 
18. Takeshi K, Makino S, Ikeda T, et al.: 1999, Direct and rapid detection by PCR of 
Erysipelothrix sp. DNAs prepared from bacterial strains and animal tissues. J Clin 
Microbiol 37:4093-4098. 
45 
 
 
19. Teixeira LM, Carvalho MG, Merquior VL, et al.: 1997, Phenotypic and genotypic 
characterization of Vagococcus fluvialis, including strains isolated from human 
sources. J Clin Microbiol 35:2778-2781. 
20. Wood RL: 1965, A selective liquid medium utilizing antibiotics for isolation of 
Erysipelothrix insidiosa. Am J Vet Res 26:1303-1308. 
21. Wood RL: 1999, Erysipelas. In: Diseases of swine, 8th: pp. 419-430. Iowa State 
University Press, Ames, IA. 
22. Wood RL, Booth GD, Cutlip RC: 1981, Susceptibility of vaccinated swine and mice to 
generalized infection with specific serotypes of Erysipelothrix rhusiopathiae. Am J 
Vet Res 42:608-614. 
23. Wood RL, Harrington R, Jr.: 1978, Serotypes of Erysipelothrix rhusiopathiae isolated 
from swine and from soil and manure of swine pens in the United States. Am J Vet 
Res 39:1833-1840. 
 
Table 1. Experimental design.  
Treatment Necropsy Group Number of 
pigs 
Serotype Reference 
strain DPI* 1 DPI 1 DPI 2† DPI 21 
1 6 1a EI-6P 4 2 2 2 
2 6 1b 422-1 2 2 2 2 
3 6 2 NF-4 2 2 2 2 
4 4 5 P-190 2 2 2 0 
5 6 10 Lengyel-P 2 2 2 2 
6 2 13 Pecs 18 0 2 0 0 
7 2 18 715 0 2 0 0 
8 2 None None 0 2 0 0 
* Days post inoculation 
† All pigs necropsied on DPI 2 were treated pigs 
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Table 2. Comparison of successful Erysipelothrix spp. isolation from different laboratory 
media.  
Direct culture Enrichment 
 BA* CNA† BA* CNA† SACV‡ 
Experimental  14/96§ 14/96 2/96 60/96 60/96 
Field Samples  13/193 16/193 18/193 163/193 163/193 
Abattoir 8/177 8/177 4/177 137/177 137/177 
Total  35/466 38/466 24/498 360/498 360/498 
* Trypticase soy agar with 5% sheep blood. 
† Colistin nalidixic acid agar with 5% sheep blood. 
‡ Sodium azide crystal violet agar (“Packer’s medium”). 
§The data are presented as isolation positive/all tissues cultured. 
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Spleen Heart Lung 
Pig  Serotype Genotype Inoculum Treatment  
Necropsy 
DPI Direct Enriched Direct Enriched Direct Enriched 
106 1a E. rhus EI-6P Non-treated 1 +* + + + + + 
148 1a E. rhus EI-6P Non-treated 1 + + + + + + 
102 1b E. rhus 422-1 Non-treated 2 + + + + - + 
103 1b E. rhus 422-1 Non-treated 2 + + - + - - 
107 1b E. rhus 422-1 Non-treated 5 - + - + - + 
152 1b E. rhus 422-1 Non-treated 5 - - - - - - 
108 2 E. rhus NF-4 Non-treated 2 + + + + - + 
159 2 E. rhus NF-4 Non-treated 2 + + + + - + 
143 2 E. rhus NF-4 Non-treated 21 - - - + - - 
145 2 E. rhus NF-4 Non-treated 21 - - - + - - 
109 5 E. rhus P-190 Non-treated 2 + + - + - + 
163 5 E. rhus P-190 Non-treated 2 - + - - - - 
151 10 E. tons Lengyel-P Non-treated 2 - + - - - - 
164 10 E. tons Lengyel-P Non-treated 2 - + - - - + 
149 10 E. tons Lengyel-P Non-treated 8 - + - + - - 
153 10 E. tons Lengyel-P Non-treated 21 - - - - - + 
155 13 E. sp. 1 Peces 18 Non-treated 2 - - - - - - 
166 13 E. sp. 1 Peces 18 Non-treated 2 - - - - - - 
105 18 E. sp. 2 715 Non-treated 2 - + - + - + 
161 18 E. sp. 2 715 Non-treated 2 - + - - - - 
Total numbers successful isolations for non-treated pigs  7/20 14/20 5/20 12/20 2/20 10/20 
147 1a E. rhus EI-6P Treated 1 - + - + - + 
144 1a E. rhus EI-6P Treated 2 - + - + - - 
111 1b E. rhus 422-1 Treated 2 - + - + - + 
165 1b E. rhus 422-1 Treated 2 - - - - - + 
101 2 E. rhus NF-4 Treated 2 - - - - - - 
157 2 E. rhus NF-4 Treated 2 - - - - - - 
160 5 E. rhus P-190 Treated 2 - + - - - - 
162 5 E. rhus P-190 Treated 2 - - - - - + 
   4
7
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Table 3. Comparison of direct and enrichment culture methods in pigs experimentally inoculated with different Erysipelothrix spp.* 
(+) indicates isolation of Erysipelothrix spp.; (-) indicates that Erysipelothrix spp. was not isolated.  
150 10 E. tons Lengyel-P Treated 2 - + - - - + 
154 10 E. tons Lengyel-P Treated 2 - - - - - - 
146 1a E. rhus EI-6P Treated 21 - - - - - - 
156 1a E. rhus EI-6P Treated 21 - - - - - - 
Total numbers successful isolations for treated pigs  0/12 5/12 0/12 3/12 0/12 5/12 
4
9
 
 
   4
8
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Table 4. Comparison of direct and enriched culture methods on field and abattoir samples.  
 Field samples  Abattoir samples 
Specimen Direct isolation Enrichment  Direct isolation Enrichment 
Skin  0/44* 41/44  0/58 44/58 
Spleen  10/44 39/44  2/26 19/26 
Liver  0/22 19/22  0/21 13/21 
Kidney 6/31 26/31  6/46 39/46 
Tonsil 0/37 32/37  0/17 16/17 
Joint aspirate 0/11 3/11  0/0 0/0 
Lung 0/4 ¾  0/9 6/9 
Total  16/193 163/193  8/177 137/177 
*Data are presented as number isolated/total number tested for each tissue.  
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CHAPTER 4. ERYSIPELOTHRIX SPP. GENOTPES, SEROTYPES, AND SURFACE 
PROTECTIVE ANTIGEN (SPA) TYPES ASSOCIATED WITH ABATTOIR 
CONDEMNATIONS 
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Abstract  
The objective of this study was to investigate characteristics of Erysipelothrix spp. 
from slaughter condemnations at a regional abattoir. Specimens from 70 carcasses with 
lesions suspect for swine erysipelas were collected at an abattoir in Iowa from October 2007 
to February 2009. Erysipelothrix spp. was isolated from 84.3% (59/70) of the carcasses. 
Abattoir inspectors classified lesion duration as acute, subacute or chronic with 8/8 (100%) 
acute cases, 31/32 (96.9%) subacute cases, and 20/30 (66.6%) chronic cases being isolation 
positive. The following serotypes were identified: 1a (40.7%; 24/59), 2 (49.2%; 29/59), 7 
(1/59), 10 (1/59), 11 (1/59) and untypeable (5.1%; 3/59). Serotypes 1a and 2 were identified 
in pigs with acute, subacute or chronic clinical manifestations whereas serotypes 7, 10 and 11 
were only present in chronic cases. Fifty-seven of the 59 isolates from positive carcasses 
were determined to belong to E. rhusiopathiae and 2/59 of the isolates were determined to be 
E. tonsillarum by multiplex real-time PCR. Surface protective antigen (spa) A was detected 
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in all recent E. rhusiopathiae isolates but not in E. tonsillarum serotypes 7 and 10. The 
results of this study indicate E. rhusiopathiae serotypes 1a and 2 continue to be commonly 
isolated serotypes in condemned pig carcasses and spaA is the exclusive spa type in U.S. 
abattoir isolates. Interestingly, E. tonsillarum which is thought of as being avirulent for swine 
was isolated from systemic sites from 3.4% of the carcasses which were negative for E. 
rhusiopathiae indicating the potential importance of this genotype in erysipelas pathogenesis.   
 
Summary of Short Communication  
Members of the genus Erysipelothrix are facultative anaerobic, slender, gram positive 
rod-shaped bacteria that cause swine erysipelas. The clinical disease associated with 
Erysipelothrix is called “erysipelas” in birds and mammals or “erysipeloid” in humans.24 
Current taxonomy recognizes the genus Erysipelothrix with two species, each with 
differentiable serotypes: E. rhusiopathiae (serotypes 1a, 1b, 2, 4, 5, 6, 8, 9, 11, 12, 15, 16, 17, 
19, 21, N), and E. tonsillarum (serotypes 3, 7, 10, 14, 20, 22, 23).15,17,19 Two proposed 
Erysipelothrix species consisting of serotypes 13 (E. sp. strain 1) and 18 (E. sp. strain 2) have 
been described.13,15,19 In addition, another proposed species, E. inopinata has also recently 
been described.21 Acute septicemia in US swine is typically associated with serotype 1a.24 
Subacute and chronic cases are typically associated with serotype 2; however, all clinical 
forms of erysipelas can be induced experimentally in susceptible pigs with serotypes 1a or 2. 
Other serotypes have less clinical significance in pigs.23,24 Recent investigations have focused 
on the surface protective antigen (Spa) of Erysipelothrix spp. as a highly immunogenic and 
protective antigen.8,20 Four different spa types described thus far and identified in 
Erysipelothrix spp. references stains banked several decades ago include spa A, spaB1, 
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spaB2, and spaC.8,14,20 A cross protection study reported complete protection with 
homologous spa but only partial protection was observed with heterologous spa strains.20 
Recently, it was determined that a certain spa type is not confined to specific serotype.5  
Economic losses associated with swine erysipelas are from increased numbers of 
deaths, treatment costs, vaccination costs, and slower growth of diseased pigs.23 In addition, 
financial loss associated with abattoir condemnations or lesion trimming is of economic 
significance. The United States Department of Agriculture (USDA) and USDA’s Food 
Safety Inspection Service (FSIS) collects data related to swine abattoir condemnations on an 
annual basis. Swine erysipelas continues to be ranked as one of the top ten causes for swine 
carcass condemnations (Courtesy of Jackie Lenzy, FOIA-2008-000440). Few studies have 
investigated isolates obtained from condemned carcasses.6,18 The objective of this study was 
to confirm the presence of Erysipelothrix in condemned carcasses and to further characterize 
the isolates obtained from a regional abattoir in the Midwestern U.S. 
Tissue specimens (tonsil, skin, kidney, liver, spleen) from a total of 70 individual 
cases representing 70 different farm sites were collected from October 2007 to February 
2009 by the veterinary inspector-in-charge at a single regional abattoir in Iowa. Utilizing 
previously described criteria, cases suggestive of swine erysipelas were visually identified 
and classified as acute, subacute, or chronic.24 Tissue specimens were collected, labeled, and 
frozen at -20°C in individual specimen bags. Frozen samples were transported to the Iowa 
State University Veterinary Diagnostic Laboratory and tested.  
Bacterial isolation was accomplished utilizing a selective broth enrichment and media 
technique and has been previously described.1,12,22 Standard laboratory methods (gram 
staining, hydrogen sulfide production) were used to confirm Erysipelothrix spp. All isolates 
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were serotyped using an agar gel precipitation test as previously described.9,11,25 One isolate 
from all culture positive carcasses was further characterized using a multiplex real-time PCR 
assay  to determine the Erysipelothrix spp. genotype as previously described13 with the 
following modification: The addition of primer (5'-
CCTTATATCTTTAGCAGGTGATCTAG-3') for Erysipelothrix spp. strain 2 was 
incorporated to increase the sensitivity of the assay.14 All isolates were also evaluated using a 
multiplex real-time PCR assay to identify the spa types (spaA, spaB1, spaB2, and spaC).14  
The isolation results of 70 condemned cases collected at the regional abattoir are 
summarized in Table 1. Of 70 cases examined, 84.3% (59/70) were found to be culture 
positive for Erysipelothrix spp. Moreover, of 350 tissue specimens cultured , which included 
tonsil, skin, kidney, liver, spleen, 58.9% (206/350) were positive. In 11.9% (7/59) of the 
carcasses, all five tissues collected from the same carcass were culture positive, in 39.0% 
(23/59) four of five tissues from the same carcass were culture positive, in 37.3% (22/59) 
three of five tissues from the same carcass were culture positive, and in 8.5% (5/59) and 
5.1% (3/59) two or one of the five tissues collected from the same carcass were culture 
positive, respectively. Overall, the highest isolation success was observed with tonsils where 
53/70 (75.7%) of the samples were positive for Erysipelothrix spp.  
All isolates recovered from different tissues of the same carcass were found to belong 
to the same serotype. The most common serotype was serotype 2 identified in 49.2% (29/59) 
of the carcasses, followed by serotype 1a identified in 40.7% (24/59) of the carcasses. Other 
serotypes detected were: serotype 7 (1 isolate); serotype 10 (1 isolate); serotype 11 (1 
isolate); and untypeable (3 isolates). Serotypes 1a and 2 were generally identified in tissues 
from pigs with acute, subacute or chronic clinical manifestations whereas serotypes 7, 10, 
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and 11 were only identified in cases with a chronic presentation (Table 1). Previous 
investigations reported an association with serotype 1a with acute disease manifestation and 
serotype 2 with subacute or chronic disease manifestation. In this study, both serotypes 1a 
and 2 were found to be present in all three clinical presentations of erysipelas. Consistent 
with previous reports is the finding that serotypes 1a and 2 are the most common serotypes 
associated with disease.4,11,16  
Fifty-seven of 59 isolates belonged to E. rhusiopathiae (including the untypeable 
isolates) and 2/59 isolates were found to be E. tonsillarum which were isolated from the 
spleen (serotype 7) or from spleen, liver, and kidney (serotype 10). Spa typing revealed that 
97% (57/59) of the isolates were positive for the spaA type, which also includes all three 
untypeable isolates. Two isolates of E. tonsillarum (serotypes 7 and 10) were found to be 
negative for the spaA type, as well as for other spa types. To the authors’ knowledge, this 
report is the first to determine the spa type in recent Erysipelothrix spp. isolates recovered 
from field cases of swine erysipelas. Based upon reference strain analysis, it is speculated 
that spa types associated with swine herds are likely highly conserved; however, additional 
field isolates need to be screened to prove the speculation. Our results are consistent with 
previous observations associating serotypes 1a and 2 with spaA.3 
The culture results from this study confirm that 84.3% (59/70) of the carcasses were 
appropriately condemned as “swine erysipelas” at a regional abattoir. Based on USDA/FSIS 
data collected from 2003 to 2008, the predominant cause for postmortem swine 
condemnation was septicemia (15.5%) followed by arthritis (4.1%) in the United States. 
However, the number of swine condemnations classified as septicemia or arthritis that may 
actually be caused by Erysipelothrix spp. is unknown since the criteria of gross lesions are 
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not etiologic-specific. Beside this, previous work demonstrated difficulties differentiating the 
acute stage of swine erysipelas from other causes of septicemia.10 Bacterial causes of arthritis 
in Canadian slaughter hogs were investigated in 1992 and E. rhusiopathiae was identified as 
the most common bacterial pathogen (45%) isolated from arthritic joints.2 For these reasons, 
the full economic and public health impact of swine erysipelas may be greatly 
underestimated. Due to constraints at the abattoir, condemnations due to septicemia or 
arthritis not highly suspected of swine erysipelas were not included in this study. With the 
development and validation of improved diagnostics assays, further investigation into cases 
of septicemia or arthritis condemned without classic “diamond skin” lesions is warranted.  
The three E. rhusiopathiae isolates, found positive for spaA type, were untypeable 
utilizing serotyping techniques. Earlier studies have described that serotype N lacks a type-
specific antigen as a result of which they fail to induce antibody production in rabbits which 
were used for producing typing antisera.7,25 This could be the probable reason for lack of 
visible precipitation lines while performing the agar diffusion test in our study. Therefore, it 
can be concluded that the isolates which were untypeable in our study may likely belong to 
serotype N. 
An unexpected finding was the presence of E. tonsillarum (serotypes 7 and 10) in two 
cases condemned for chronic erysipelas. Interpretation of the importance of E. tonsillarum is 
difficult as it can be frequently isolated from tonsils of normal swine24 and it is reported to be 
of little pathologic significance.17 Recent work demonstrated that strains belonging to E. 
tonsillarum serotype 10 induced generalized urticarial skin lesions after intradermal 
inoculation; however, E. tonsillarum serotype 7 induced no clinical signs or macroscopic 
lesions.17 In this study, E. tonsillarum was the only pathogen (E. rhusiopathiae was not 
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detected) isolated from internal organs (spleen, liver, kidney) of these two condemned cases, 
suggesting that E. tonsillarum may be more important in pigs than previously speculated. 
The spa PCR was negative for spaA, spaB1, spaB2, and spaC on the E. tonsillarum isolates 
recovered from the carcasses which is consistent with previous studies.20 Additional 
investigations to determine the full impact of E. tonsillarum strains is warranted. Recent 
evidence of the immunogenic properties of the Spa protein suggests this virulence factor may 
better predict pathogenicity than the serotype of the isolate.  
Constraints at the abattoir prevented trace-back of condemned cases to the farm of 
origin, therefore it remains unknown if the condemned carcasses had been vaccinated against 
erysipelas. Commercial killed and attenuated-live vaccines are derived from serotype 1a.11 It 
can be speculated that a pig vaccinated with a product containing serotype 1a should be 
protected against serotypes 1a and 2 based on previous studies using homologous spa types.20 
The E. tonsillarum isolates were found to contain no Spa types, suggesting a mechanism for 
a lack of protection from currently available vaccines. Future investigations of swine 
erysipelas should include Spa typing of vaccines if utilized on site, recognizing that 
immunization failures also occur for other reasons. 
Results of this study indicate that cases of suspected of swine erysipelas condemned 
at an abattoir were appropriately classified. In addition, the majority of isolates recovered 
indeed belong to E. rhusiopathiae serotypes 1a and 2. In contrast to previous studies; 
however, the presence of these serotypes was demonstrated in carcasses with lesions at all 
stages (acute, subacute and chronic). Furthermore, an important novel finding in this study is 
the association of E. tonsillarum strains with condemned tissue specimens. Based on our 
findings, E. rhusiopathiae may play a more significant role than previously suspected. 
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Alternatively, the findings could be due to carcass contamination. Investigations at additional 
abattoirs in the United States are necessary as these results are based on condemnations at a 
single abattoir utilizing a single inspector.  
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Table 1: Swine erysipelas suggestive lesions and criteria for determination of the lesion   
stage at the abattoir. 
Presentation Location Criteria 
Skin Raised dark red to dark purple urticarial changes  
Lymph node 
Kidney 
Hyperemic, hyperplastic, or hemorrhagic changes  
Hemorrhagic lesions 
Acute 
Other Additional systemic organ signs of septicemia 
Skin Light pink to light purple discoloration 
Subacute 
Kidney Minimal renal changes  
 Lymph node Edematous changes  
Chronic Kidney Renal infarcts  
 Joints Arthritic joint changes  
 
Table 2: Association of lesion duration and successful Erysipelothrix spp. isolation in     
selected tissues. Data presented as number isolated/total number tested for each tissue. 
Erysipelas 
Presentation Tonsil Skin Kidney Liver Spleen Total 
Acute 8/8 8/8 5/8 4/8 5/8 30/40 
Subacute 26/32 24/32 19/32 16/32 21/32 106/160 
Chronic 19/30 10/30 14/30 11/30 16/30 70/150 
Total 53/70 42/70 38/70 31/70 42/70 206/350 
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Table 3: Number of Erysipelothrix spp. isolation positive cases by lesion stage with 
associated serotypes. 
Presentation Successful isolation Serotype Genotype Spa Type 
Serotype 1 (5/8) E. rhusiopathiae A 
Acute 8/8 
Serotype 2 (3/8) E. rhusiopathiae A 
Serotype 1 (15/31) E. rhusiopathiae A 
Serotype 2 (14/31) E. rhusiopathiae A Subacute 31/32 
Untypeable (2/31) E. rhusiopathiae A 
Serotype 1 (4/20) E. rhusiopathiae A 
Serotype 2 (12/20) E. rhusiopathiae A 
Serotype 7 (1/20) E. tonsillarum ND* 
Serotype 10 (1/20) E. tonsillarum ND* 
Serotype 11 (1/20) E. rhusiopathiae A 
Chronic 20/30 
Untypeable (1/20) E. rhusiopathiae A 
*ND: Isolates were negative for Spa A, B1, B2, and C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
63 
 
CHAPTER 5.  CHARACTERIZATION AND COMPARISON OF ERYSIPELOTHRIX  
SPP. ISOLATES FROM CLINICALLY AFFECTED PIGS, ENVIRONMENTAL 
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Abstract 
The aim of this study was to characterize Erysipelothrix spp. isolates from clinically affected 
pigs and their environment and compare them to the Erysipelothrix spp. vaccines used on the 
sites. Samples were collected from swine erysipelas outbreaks in vaccinated pigs in six 
Midwest United States swine operations during 2007 to 2009. Pig tissue samples were 
collected from 1-3 pigs on each site. Environmental samples (manure, feed, central line 
water, oral fluids and swabs collected from walls, feed-lines, air inlets, exhaust fans and 
nipple drinkers) and vaccine samples were collected following the isolation of Erysipelothrix 
spp. from clinically affected pigs. All Erysipelothrix spp. isolates obtained were further 
characterized by serotyping. Selected isolates were further characterized by PCR assays for 
genotype (E. rhusiopathiae, E. tonsillarium, E. sp. strain 1 and E. sp. strain 2) and surface 
protective antigen (spa) type (A, B1, B2 and C). All twenty-six isolates obtained from 
affected pigs were E. rhusiopathiae, specifically, serotypes 1a, 1b, 2 and 21. In 
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environmental samples, 56 isolates were obtained and 52/56 were E. rhusiopathiae 
(serotypes 1a, 1b, 2, 6, 9, 12 and 21), 3/56 were E. sp. strain 1 (serotypes 13 and untypeable) 
and one novel species designated as E. sp. strain 3 (serotype untypeable). Four of six 
vaccines used on the sites were commercially produced products and contained E. 
rhusiopathiae serotype 1a. Of the remaining two vaccines, one was an autogenous vaccine 
and contained E. rhusiopathiae serotype 2 and one was a commercially produced inactivated 
vaccine and was not further characterized. All E. rhusiopathiae isolates were positive for spa. 
All E. sp. strain 1 isolates and the novel E. sp. strain 3 isolate were negative for all currently 
known spa types (A, B1, B2 and C). Results indicate that Erysipelothrix spp. can be isolated 
from the environment of clinically affected pigs; however, the identified serotypes in pigs 
differ from those in the environment on selected sites. The vaccine strain and the isolates 
identified in clinically affected pigs were identical on one of five sites but dissimilar on four 
of five sites suggesting that re-evaluation of vaccine efficacy using recent field strains may 
be warranted. 
Introduction 
Organisms of the genus Erysipelothrix are facultative anaerobic, small slender gram 
positive rods with worldwide distribution. Erysipelothrix spp. have been isolated from 
domestic and wild species of both birds and mammals and have been identified as the 
causative agent of the clinical disease known as “erysipelas” in animals and “erysipeloid” in 
humans (2). The genus Erysipelothrix consists of four species and 25 associated serotypes: E. 
rhusiopathiae (serotypes 1a, 1b, 2, 4, 5, 6, 8, 9, 11, 12, 15, 16, 17, 19, 21, N), E. tonsillarium 
(serotypes 3, 7, 10, 14, 20, 22, 23), E. sp. strain 1 (serotype 13) and E. sp. strain 2 (serotype 
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18) (24,27). Among the four species, E. rhusiopathiae causes greatest economic losses, 
primarily to the swine and turkey industries (32,34).  
Three clinical presentations of swine erysipelas are recognized: Acute disease (often 
associated with serotype 1a), subacute disease (often serotype 2) and chronic disease (often 
serotype 2). The additional serotypes (3-26, N) have minimal clinical significance in swine 
(34). It is estimated that 30 to 50% of healthy pigs harbor E. rhusiopathiae in tonsils and 
lymphatic tissue. Subclinically affected pigs are thought to be the source for acute erysipelas 
outbreaks due to shedding of the organism in urine, feces, saliva and nasal secretions (34).  
Economic losses due to swine erysipelas continue to occur worldwide. For this 
reason, accurate, reliable and timely diagnostic strategies are continuing to be developed to 
address conventional diagnostic limitations, including: small colony size, slow rate of growth 
and potential specimen contamination (3). Immunohistochemistry techniques have been 
shown to be highly sensitive and specific, especially when diagnostic specimens include 
lesions from antimicrobial-treated pigs or chronically affected pigs (15). Recently, an 
Erysipelothrix spp. selective broth enrichment technique was found to be more sensitive than 
traditional direct bacterial culture on regular and contaminated specimens (1). PCR 
technology is also being employed to complement traditional detection methods (9,18,27,36). 
In addition to improved diagnostic assays, methods to further characterize and differentiate 
Erysipelothrix spp. through the use of randomly amplified DNA, pulsed-field gel 
electrophoresis and ribotyping have been shown to be useful and credible (12-14,16). Recent 
investigations have focused on antibodies against the cell surface components of E. 
rhusiopathiae and their protective role. Genes encoding surface protective antigens (Spa) 
have been cloned and nucleotide sequences have been determined (10,21). Spa-related genes 
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of all E. rhusiopathiae serotypes and E. sp. strain 2 (serotype 18) were analyzed and Spa 
proteins could be classified into three molecular species, SpaA, SpaB and SpaC (28). The 
SpaA protein was identified in E. rhusiopathiae serotypes 1a, 1b, 2, 5, 8, 9, 12, 15, 16, 17 
and N, the SpaB protein was identified in E. rhusiopathiae serotypes 4, 6, 11, 19, 21 and the 
SpaC protein was only identified in serotype 18 (28). Additional work further differentiated 
Spa B into subtypes SpaB1 (serotypes 4, 6, 8, 19, 21) and SpaB2 (serotype 11) (20).   
Previous characterization of Erysipelothrix spp. isolates from affected pigs or isolates 
from the environment on U.S. swine sites dates back to the 1970’s. The objective of this 
study was to identify, characterize and compare Erysipelothrix spp. isolates from affected 
pigs and the environment from erysipelas outbreaks on six Midwest swine operations and to 
compare those isolates to the vaccine strains routinely used for vaccination in those same six 
operations.  
 
Materials and Methods 
Site selection 
Tissue specimens submitted to the Iowa State Veterinary Diagnostic Laboratory 
(ISU-VDL) between December 2007 and February 2009 obtained from pigs that had a 
clinical history consistent with acute septicemia (fever, lethargy, skin lesions, decreased feed 
intake) or chronic changes (swollen joints, lameness) suggestive of swine erysipelas were 
tested for presence of Erysipelothrix spp. Upon receipt at ISU-VDL tissue specimens were 
immediately cultured. Following a positive isolation, the submitting veterinarian was 
contacted to determine the vaccination status of the herd. Swine sites utilizing an active 
vaccination program against E. rhusiopathiae were selected, visited and environmental 
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samples were collected. A total of six sites fitted the above described criteria and were 
selected for this study. The sites were located in the United States, specifically in Illinois 
(one site), Indiana (one site), and Iowa (four sites) and the samples were collected during 
2007 and 2009. The farm structures, types, and clinical signs present on the farms are 
summarized in Table 1. All sites housed pigs in confinement and utilized automatic feeders 
and waters.  
 
Pig samples 
Sections of spleen, liver, lung, tonsil, kidney, and skin were collected from clinically 
affected pigs. A total of 31 samples from 1-3 pigs on each of the six sites were tested. The 
samples were immediately cultured. Representative samples were frozen at -80° C for future 
evaluation.  
 
Environmental samples 
Environmental samples were collected from areas where swine tend to congregate 
and interact.36 Using sterile Culturette™ swabs (Becton Dickinson, Sparks, Maryland, USA), 
samples were collected from the following locations: Water supply areas (nipple drinker, 
diaphragm), wall surfaces, feed-lines and inlet/outlet exhaust fans. Feed, manure and water 
samples were collected directly into sterile 50 ml falcon tubes (Thermo Fischer Scientific 
Remel, Lenexa, Kansas, USA). For purposes of this study, oral fluid samples were also 
classified as environmental samples as they were collected on site and not from the same pigs 
from which tissue specimens were collected. Oral fluids were only collected from sites C and 
D. In brief, a 3-strand cotton rope was placed in pens with 4 to 6 pigs. The rope was 
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approximately shoulder length based upon the size of the pigs. Ropes were left in place for 
20-30 minutes. Oral fluids were then collected by cutting the bottom 30.5 cm of the rope and 
mechanically compressing fluid samples into sterile 5 ml snap cap tubes.20 All environmental 
samples were immediately placed on ice following collection and stored at -20° C until 
testing. Testing was done within 3 months after collection. 
 
Vaccine strains  
Four attenuated-live vaccine strains (sites A, B, D and E), one autogenous vaccine 
strain (Farm F), and one inactivated vaccine strain (site C) were collected. Attenuated-live 
vaccines included ERY VAC 100 (Arko Laboratories Limited, Jewell, Iowa, USA) which 
was used on sites A and B, Suvaxyn® E-oral (Fort Dodge Animal Health, Inc., Fort Dodge, 
Iowa, USA) which was used on site D and Ingelvac® ERY-ALC (Boehringer Ingelheim 
Vetmedica, Inc., St. Joseph, Missouri, USA) which was used on site E. Site F utilized an 
attenuated-live autogenous strain produced by using a farm-specific isolate. Site C utilized 
used Suvaxyn® Parvo/E (Fort Dodge Animal Health, Inc., Fort Dodge, Iowa, USA) which is 
an inactivated vaccine strain and which was not included in the analysis. The five attenuated 
live vaccine strains were immediately placed on ice following collection and stored at -20° C 
until testing. Testing was done within 3 months after collection. 
 
Bacterial isolation 
An Erysipelothrix spp. selective broth protocol as previously described2 was utilized 
for bacterial isolation. The selective broth was prepared as follows: In 1 liter of 0.1 phosphate 
buffer solution (12.02 g of Na2HPO4 and 2.09 g of KH2PO4 per liter of distilled water) 25 g 
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heart infusion broth (Becton Dickinson) was dissolved and the resulting solution was 
autoclaved. Five-percent sterile fetal bovine serum (Sigma-Aldrich, St Louis, Missouri, 
USA), kanamycin (Sigma-Aldrich) (400 mg/ml) and neomycin (Sigma-Aldrich) (50 mg/ml) 
were added to the broth.31 Specimens were cultured on an Erysipelothrix spp. selective agar 
as previously described. Briefly, 33 g tryptose agar base, 5 g Bacto™ tryptose, and 3 g 
granulated agar were dissolved in 920 ml distilled water. After autoclaving, the agar was 
cooled to 48° C and 4 ml of crystal violet stock solution (Thermo Fischer Scientific Remel), 
25 ml of sodium azide stock solution (Thermo Fischer Scientific Remel), and 50 ml of sterile 
bovine blood were added before aseptically dispensing into sterile petri plates. Stock 
solutions of sodium azide crystal violet agar were made in distilled water at a concentrations 
of 4.0% and autoclaved.17  
 
Sample preparation  
Tissue specimens. Samples were cut into 2 × 3 cm sections, added to 2 ml of 0.85% 
physiologic saline solution, homogenized using a stomacher (Seward, Bohemia, New York 
USA), and 300 ul of resulting tissue homogenate was added to the Erysipelothrix spp. 
selective broth and incubated at 35° C for 24 to 48 hrs. At 24 hrs and again at 48 hrs, a 100 ul 
subculture from the Erysipelothrix selective broth was made onto a trypticase soy agar plate 
containing 5% sheep blood, a colistin-nalidixic acid (Becton-Dickinson) agar containing 5% 
sheep blood, and an Erysipelothrix selective plate as described.2 Colonies were subcultured 
on sheep blood agar plates, incubated for 24 hrs, and then biochemically confirmed using 
standard laboratory methods.25,31  
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Water and oral fluids. For samples of a liquid consistency, 300 µl of each specimen 
was added to the Erysipelothrix spp. selective broth and incubated.  
Swabs and vaccines. Culturette™ swabs and vaccine samples were placed directly 
into the Erysipelothrix spp. selective broth.  
Manure and feed samples. A portion of the sample (75 to 100 g) was placed into 
sterile flasks, adding 0.1 M phosphate buffer solution, and mixing the homogenate for 10 min 
utilizing magnetic metal stir bars. The homogenate was then transferred to centrifuge tubes 
and centrifuged for 10 min at 1,000 rpm. The supernatant was transferred to a flask to which 
250 ml of the Erysipelothrix spp. selective broth was added. Each flask was thoroughly 
mixed, incubated at 35° C for 24 hrs, and then subcultured to media similarly to tissue and 
liquid specimens.36  
 
Further characterization of the Erysipelothrix isolates 
Serotyping. A pure culture was grown at 37° C for 36 hrs in 30 ml of heart infusion 
broth (Becton-Dickinson) supplemented with 10% equine serum (Sigma-Aldrich).35 The 
culture was then killed by adding 1% formalin (Sigma-Aldrich), held at room temperature for 
12 hrs, harvested by centrifugation, and washed twice in 0.85% NaCl solution containing 
0.5% formalin. Washed cells were suspended in 1.5 ml of distilled water and autoclaved at 
121° C for 1 h.35 The supernatant was collected and used for the agar gel precipitation test.11 
Homologous positive controls were used with each test run. Reactions were recorded after 24 
hrs.35   
Genotype multiplex PCR assay. Further characterization was done on randomly 
selected representative isolates of each serotype collected on each site. A multiplex real-time 
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PCR assay described was used to confirm and determine the presence of E. rhusiopathiae, E. 
tonsillarum, and E. species strain 2.19 The modified E. sp. strain 2 primer was utilized to 
increase the sensitivity of the assay as described.21  
Identification of E. sp. strain 1 by SP1 conventional PCR assay. A pair of specific 
primers Sp11508F (5’-AGACGAAAGCGGCGATTACT-3’) and Sp12362R (5’-
CCCCTACCACTTGCATTTAATGC-3’) were designed in the 16S ribosomal RNA gene of 
E. sp. strain 1 (GenBank accession No. AB019249). The PCR reaction was performed in a 
GeneAmp® PCR system 9700 (Applied Biosystems, Foster City, California, US) in 25 µl 
mixtures containing 1.25 U (0.25 µl) Taq DNA polymerase (Invitrogen, Carlsbad, California, 
USA), 0.2 mM dNTP, 0.4 µM of each of the primers, 1.5 mM MgCl2, and 4µl DNA extract. 
The cycling conditions were 5 min at 95 °C, followed by 35 cycles of 40 s at 95 °C, 40 s at 
55 °C and 1 min at 72 °C, and finally extension at 72 °C for 7 min. The amplified PCR 
products were separated by gel electrophoresis on a 1% agarose (Amresco, Solon, Ohio, 
USA) gel and visualized by UV irradiation after ethidium bromide staining of the gel. The 
specificity of the SP1 conventional PCR assay was investigated by testing E. rhusiopathiae 
reference strains Tuzok (serotype 6), E. tonsillarum reference strain Lengyel-P (serotype 10), 
E. sp. strain 2 reference strain 715 (serotype 18) and E. sp. strain 1 reference strain Pécs 18 
(serotype 13). A specific product of 855 bp was amplified from E. sp. strain 1 reference 
strain, whereas no PCR products were amplified from the isolates used. The sensitivity of 
this conventional PCR was determined to be 1×104 CFU per reaction (data not shown). 
Spa-type multiplex real-time. A multiplex real-time PCR assay was utilized for 
identification of the Spa type present (Spa A, Spab1, SpaB2, and SpaC) on the same isolates 
that were also used for genotyping.21 
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Results 
Isolation and further characterization of the obtained isolates (Genotype, serotype and 
spa type) 
Clinically affected pigs. Among the pig tissue samples examined, 83.9% (26/31) were 
found to be positive for Erysipelothrix spp. Skin samples were received from all six sites and 
100% (11/11) of the skin samples were found to be culture positive. Erysipelothrix spp. was 
also isolated from all tonsil (5/5) and kidney (3/3) samples obtained; however, these sample 
types were not submitted from every site. The isolation success was 50% for heart tissues 
(1/2) and liver (2/4) and 66.7% for spleen (4/6). All 26 isolates were found to belong to E. 
rhusiopathiae. All E. rhusiopathiae isolates recovered from the same site were found to 
belong to the same serotype. The more common serotypes in affected pigs were serotypes 1a 
(sites D and F) and 2 (sites A and B). In addition, serotype 21 was present in pigs from site C 
and serotype 1b was identified in pigs from site E. All 26 E. rhusiopathiae isolates recovered 
from pig tissues were determined to be positive for spaA. 
Environmental samples. Of 142 environmental samples examined, 39.4% (56/142) 
were found to be culture positive for Erysipelothrix spp. Genotyping revealed that 92.9% 
(52/56) of the environmental isolates belonged to E. rhusiopathiae, 5.4% (3/56) belonged to 
E. species strain 1 the genotype was not determinable in 1.8% (1/56) of the obtained isolates. 
The most commonly identified serotype was 1a which was identified in 37.5% (21/56) of the 
isolates followed by serotype 2 (33.9%; 19/56), serotype 1b (10.7%; 6/56) serotypes 6 and 21 
(each 3.6%; 2/56), and serotypes 9, 12 and 13 (each 1.8%; 1/56). The serotype of 5.4% (3/56) 
of the isolates was not determinable. All environmental isolates identified as E. rhusiopathiae 
were found to be positive for spaA and all isolates identified as E. species strain 1 or with an 
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undeterminable genotype were negative for spaA, B1, B2, and C. The frequency of detection 
of Eryipelothrix spp. in environmental samples is summarized in Table 2 with water, waterer, 
feed, manure, wall swabs and oral fluids as the samples that had the highest positive isolation 
rate. Serotypes were also detected in clinically affected pigs were found in manure, feed, wall 
swabs, water, waterer, and fan for serotype 1a, water and waterer for serotype 1b, manure, 
feed, wall swabs, water and fan for serotype 2, and oral fluid for serotype 21.  
Vaccine strains. All four attenuated-live vaccine strains were identified as E. 
rhusiopathiae serotype 1a and the autogenous vaccine strain used on site F was identified as 
E. rhusiopathiae serotype 2. All five vaccine strains were positive for spaA.   
 
Isolation success and distribution of isolates from the different sites 
Site A. A total of 7 samples from affected pigs were obtained and 43 environmental 
samples were collected (Table 3). E. rhusiopathiae serotype 2 was isolated from 5/7 tissues 
and from 18/43 environmental samples (waterer swabs, manure, wall swabs, feed, and fan). 
In addition, E. rhusiopathiae serotype 1a was identified in 2 feed samples and the attenuated 
live-vaccine strain used on farm also contained serotype 1a.  
Site B. A total of 5 samples from affected pigs were obtained and 39 environmental 
samples were collected (Table 3). E. rhusiopathiae serotype 2 was isolated from all tissue 
samples and from 1 waterer swab. E. rhusiopathiae serotype 1a was isolated from 8 
environmental samples (water, manure, wall swab and feed) and was also identified in the 
vaccine sample. In addition, E. rhusiopathiae serotype 6 was isolated from a water sample 
and a waterer swab and E. rhusiopathiae serotype 2 was isolated from a waterer swab. 
Serotype 13 (E. species strain 1) was isolates from a water sample.  
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Site C. A total of 3 samples from affected pigs were obtained and 12 environmental 
samples were collected (Table 3). E. rhusiopathiae serotype 21 was isolated from all tissue 
samples and from two oral fluid samples. As the vaccine strain was inactivated, its serotype 
couldn’t be determined.  
Site D. A total of 2 samples from affected pigs were obtained and 12 environmental 
samples were collected (Table 3). E. rhusiopathiae serotype 1a was isolated from all tissue 
samples but was not identified in any of the environmental samples collected. Instead, E. 
rhusiopathiae serotypes 9 and 12 were isolated from oral fluids and E. species strain 1 was 
isolated from oral fluid and manure (serotype undeterminable). One additional isolate 
(genotype and serotype undeterminable) was isolated from manure. The vaccine used on this 
site contained E. rhusiopathiae serotype 1a. 
Site E. A total of 6 samples from affected pigs were obtained and 6 environmental 
samples were collected (Table 3). E. rhusiopathiae serotype 1b was isolated from all tissue 
and environmental samples. The vaccine strain used on site E was determined to be E. 
rhusiopathiae serotype 1a. 
Site F. A total of 8 samples from affected pigs were obtained and 11 environmental 
samples were collected (Table 3). E. rhusiopathiae serotype 1a was isolated from all tissue 
and environmental samples. The autogenous vaccine strain used on site was determined to be 
E. rhusiopathiae serotype 2. 
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Discussion 
Results from this investigation indicate that during a clinical outbreak of swine 
erysipelas, Erysipelothrix spp. can be isolated from a variety of environmental samples. 
Earlier investigations on swine erysipelas conducted in the United States have reported 
similar results on identifying Erysipelothrix spp. from swine and swine production premises; 
however, studies have not been conducted on sites with acute swine erysipelas outbreaks 
(33,35). Interestingly in this study we identified three E. sp. strain 1 isolates (1/3 serotype 13, 
2/3 untypeable), indicating the possibility of one or more new serotypes within E. sp. strain 1 
in addition to serotype 13. Moreover, a new genotype of Erysipelothrix designated as E. sp. 
strain 3 was identified in an environmental sample, whose serotype and spa type were also 
unknown indicating the possibility of a new serotype within the species. 
When tissues from affected pigs were investigated, it was found that skin specimens 
with visible rhomboid lesions were consistently culture positive, implicating skin as the 
tissue of choice for isolation of Erysipelothrix spp. which is in agreement with previous work 
(1). In addition, all tested tonsil samples (5/5) were also found to be culture positive. The 
existence of Erysipelothrix spp. in the tonsils of healthy pigs is suspected (23); however, in 
the current study, all selected isolates obtained from tonsils had the same serotype when 
compared to isolates recovered from other organs of affected pigs. E. rhusiopathiae serotypes 
1a, 1b and 2 are commonly associated with clinical disease in pigs and were associated with 
clinically affected pigs in 5/6 sites. Interestingly, serotype 21 was found in affected pigs from 
one of the six sites. While uncommon, this has been reported previously in a larger study that 
characterized 1,046 isolates recovered from pigs with swine erysipelas in Japan and found 
that 1.1% of Erysipelothrix spp. isolates belonged to serotype 21 (25).  
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Among environmental samples, Erysipelothrix spp. was most frequently isolated in 
feed and nipple drinkers (both 9/17 samples). This was followed by isolation from wall 
swabs (11/23 samples) and manure (13/28 samples). While isolation of Erysipelothrix spp. 
has been described from manure and soil (30), to our knowledge this is the first description 
of isolation of Erysipelothrix spp. from nipple drinkers, walls and ventilation fans. Although 
clinical disease was present on all sites, a relatively high percentage of environmental 
samples were culture negative (53.5% on site A; 69.2 on site B; 93.5% on site C; and 41.7% 
on site D). This may have to do with the total number of samples collected, the sample types, 
storage, delay between the original case submission and follow-up site visit, or may be 
related to shedding mechanisms of Erysipelothrix spp. Previous studies demonstrated no 
evidence of growth or maintenance of Erysipelothrix spp. in soil or manure samples from 
swine pens (31). The role of soil, manure and pit slurry as a reservoir or source of infection is 
not completely understood (32).  
The attenuated-live vaccine strains utilized on the different sites were also collected, 
cultured and characterized. All sites in this investigation utilized a vaccine as part of an 
erysipelas control plan. Four of six sites (sites A, B, D and E) utilized attenuated-live 
vaccines, produced by three manufacturers. All three of these commercially available 
vaccines were found to be positive for E. rhusiopathiae serotype 1a. Interestingly, 2 of the 4 
sites using these vaccines had clinical infections with  serotype 2, 1 of the 4 sites with 
serotype 1b and one site with serotype 1a based on the isolation of these serotypes from 
affected pigs. One site (F) used an autogenous attenuated-live vaccine based on a site-
specific isolate. The isolate recovered from the autogenous vaccine was identified as serotype 
2; however, E. rhusiopathiae serotype 1a was isolated from affected pigs from this site and 
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was also the only serotype present in the environment. Many factors affect the ability of a 
live vaccine to elicit protection, including but not limited to: vaccine storage; route and dose 
of administration; age; maternal immunity; antimicrobial therapy and vaccine strains used. 
Based on cross-protection studies done in the 1980’s, it was found that serotype 1a protected 
against serotype 1b and 2 (26). Cross-protection was apparently not sufficient to prevent 
clinical disease in this case providing evidence of the need to further evaluate cross-
protection in the swine model using recent field isolates.  
In this study Erysipelothrix spp. was able to be isolated from the environment of 
clinically affected swine. In addition, the Erysipelothrix spp. isolates recovered from 
clinically affected pigs and the majority of the Erysipelothrix spp. isolates recovered from 
their environment were found to be identical in four of the six sites (site A, serotype 2; site C, 
serotype 21; site E, serotype 1b; and site F, serotype 1a). However, dissimilarities between 
isolates in pigs and their environment were identified in 2 of the 6 sites investigated. While 
pigs in these sites were infected with very common serotypes (serotypes 1a or 2), a variety of 
serotypes were identified in the environment (serotypes 1a, 2, 6, 9, 12, 13 and untypeable). 
The absence of disease-causing isolates in the environment supports assertions that the pig is 
the most important reservoir and carrier of Erysipelothrix spp.; however, the pathogenicity of 
environmental isolates was not tested. The stability of serotypes in the environment is 
unknown as various reversible changes occurred after repeated in vitro passage of serotypes 
1, 2 and N (5). In contrast, it has been determined that E. rhusiopathiae serotypes remain 
stable through swine serial passage or under different storage conditions (22,29). In this 
investigation serotypes identified in the environment were both identical (4/6 sites) and 
contrasting (2/6 sites) to what was isolated from clinically affected pigs from these sites; 
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however, affected sites were visited only once. To fully understand the interactions and 
relations between isolates associated with disease in pigs and isolates present in the 
environment, repeated collection over time of samples would provide a more complete 
timeline.   
In this study all recovered isolates were also tested for their dominant spa type. To the 
authors’ knowledge, this is the first report of spa type characterization in Erysipelothrix spp. 
isolates obtained from clinical swine erysipelas outbreaks. The Spa protein of E. 
rhusiopathiae has been shown to be attached at the cell surface level of the bacteria and also 
to be the main protective antigen against infection by E. rhusiopathiae (6,7,10,28). All E. 
rhusiopathiae isolates obtained from affected pig tissues (serotypes 1a, 2, 21), environmental 
samples (serotype 1a, 1b, 2, 6, 9, 12 and 21) and vaccine strains (serotypes 1a and 2) were 
found to contain a single spa type, spaA. The identification of spaA in serotype 21 is in 
contrast to a previous report where spaB was identified (28); however, in agreement with 
another study which reported serotype 21 as expressing SpaA (8). Moreover, the findings of 
this study support previous results that spaA is highly conserved in serotypes most often 
associated with clinical swine erysipelas (8). All five vaccine strains characterized were 
found to be positive for spaA and based on the current state of knowledge cross-protection 
should have occurred (8,28). However, the role of vaccine handling, administration and 
timing should not be overlooked and can be considered a potential explanation for the lack of 
protection. All three E. sp. strain 1 isolates and the E. sp. strain 3 isolate were found to be 
negative for all spa types investigated (A, B1, B2, C). These isolates were identified in two 
of the four sites and were present in central line water, oral fluid and manure. Outbreaks 
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associated with E. sp. strain 1 have not been reported and the importance of these isolates is 
currently unknown.  
Data from acute swine erysipelas outbreaks investigated in this study indicate that during an 
acute outbreak situation Erysipelothrix spp. can be isolated from both clinically affected pigs 
and their environments. Characterization of the Erysipelothrix spp. isolates using serotyping 
and genotyping assays indicated that isolates in affected pigs and the environment are not 
necessarily the same on individual sites. Despite 120 years of experience with the organism, 
little is known regarding transmission and shedding of Erysipelothrix spp. Further work 
examining additional swine sites and experimentally infected pigs is necessary to provide 
more information on shedding characteristics of acutely infected pigs with erysipelas. Much 
interest has recently been generated regarding spa types. Results of this study agree with 
previous work and indicate that spa types are likely quite conserved amongst swine isolates 
of Erysipelothrix spp. associated with disease. 
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Table 1. Characteristics of the six swine operations used in this study. 
Site Type Pigs# Percentage 
affected 
Clinical Signs 
A Finisher 1,200 3% Rhomboid skin lesions, swollen joints, lethargy 
B Finisher 2,200 2% Rhomboid skin lesions, swollen joints, lameness, pyrexia, lethargy 
C Breeding herd 1,600 2% 
Swollen joints, lameness, 
abortions 
D Boar stud 150 1% Rhomboid skin lesions, swollen joints, lameness 
E Finisher 2,400 2% Rhomboid skin lesions, lameness 
F Breeding herd 1,100 4% 
Acute death, rhomboid skin 
lesions, skin cyanosis, abortions 
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Table 2. Isolation success of Erysipelothrix spp. in different environmental samples and associated genotypes and serotypes. 1 
Sample type Positive isolation Negative Percentage of 
positive samples 
Genotypes identified Serotypes identified 
Manure 13 15 46.4% E. rhusiopathiae, E. 
sp. strain 1, 
undeterminable 
1a, 2, untypeable 
Oral fluid 5 6 45.5% E. rhusiopathiae, E. 
sp. strain 1 
9, 12, 21, untypeable 
Feed 9 8 52.9% E. rhusiopathiae 1a, 2 
Feed line 0 7 0%   
Wall swab 11 12 47.8% E. rhusiopathiae 1a, 2 
Water 6 22 21.4% E. rhusiopathiae, E. 
sp. strain 1 
1a, 1b, 6, 13 
Waterer 9 8 52.9% E. rhusiopathiae 1a, 1b, 2, 6 
Fan 3 8 27.3% E. rhusiopathiae 1a, 2 
 2 
 
8
5
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Table 3. Positive isolation and serotypes in tissues from clinically affected pigs obtained 
from six different sites and their environment.  
Site 
 
Samples from 
affected pigs  
Positive/ 
total samples 
Serotypes 
in pig 
tissues 
Environmental 
samples 
Positive/ 
total samples 
Serotypes in 
environmental 
samples 
Skin 2/2 2 Water 0/6 2 
Tonsil 1/1 2 Waterer swab 2/4 2 
Spleen 1/2 2 Manure 7/12 2 
Liver 1/2 2 Wall swab  6/8 2 
   Feed line swab  0/4   
   Feed  3/5 1a (2/3), 2 
A 
     Fan/inlet swab 2/4 2 
Skin 2/2 2 Water 4/9 1a (2/4), 6, 13 
Kidney 1/1 2 Waterer swab 2/5 2, 6  
Spleen 1/1 2 Manure 1/5 1a 
Tonsil 1/1 2 Wall swab 2/8 1a 
   Feed line swab 0/3   
   Feed  3/6 1a 
B 
     Fan/inlet swab 0/3   
Skin 1/1 21 Oral fluid 2/4 21 
Tonsil 1/1 21 Water 0/9   
Spleen 1/1 21 Waterer swab 0/3   
   Manure 0/6   
   Wall swab 0/3   
   Feed  0/3   
C 
     Fan/inlet swab 0/3   
Skin 2/2 1a Oral fluid 3/7 9, 12, untypeable 
   Water 0/2  
   Manure 2/2 untypeable 
D 
   Wall swab 0/1   
Skin 2/2 1b Water 2/2 1b 
Tonsil 2/2 1b Waterer swab 2/2 1b E 
Spleen 1/2 1b Feed  2/2 1b 
Skin 2/2 1a Waterer swab 3/3 1a 
Liver 1/2 1a Manure 3/3 1a 
Heart 1/2 1a Wall swab 3/3 1a 
Kidney 2/2 1a Feed  1/1 1a 
F 
   Fan/inlet swab 1/1 1a 
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CHAPTER 6.  GENERAL CONCLUSIONS  
 
Summary and General Conclusions  
 The studies presented in this dissertation address improved diagnostics and further 
characterization of Erysipelothrix isolates obtained from condemned carcasses at slaughter 
and acute swine erysipelas outbreaks.  Few studies have been published from authors 
examining swine erysipelas in the United States for the past 20-30 years since the work of 
Dr. Richard L. Wood.  However, swine erysipelas continues to cause economic losses to the 
swine industry due to condemnations at slaughter, decreased growth rates, and reproductive 
failures in addition to treatment and vaccination costs.  Questions have been raised recently 
by field veterinarians and diagnosticians as to the characterization of currently encountered 
field isolates.  With minimal recent research in the field of swine erysipelas substantial 
questions regarding the diversity of field isolates have been raised.  To best answer these 
questions it was quickly noticed that prior to further characterization of field isolates, 
diagnostic methods would first have to be improved.   
 Considerable research regarding different isolation techniques has been conducted.  
Despite the vast array of described protocols, a survey of Midwestern United States 
diagnostic laboratories indicated that when presented with a set of tissues suspected of swine 
erysipelas, no additional techniques other than direct primary culture were being utilized.  An 
additional complicating factor is the lack of published reports comparing methods for the 
isolation of Erysipelothrix.  In order to address questions related to Erysipelothrix culture 
methods, an investigation was performed which compared the diagnostic sensitivity of a 
broth-based enrichment technique and direct primary culture.  The broth-based enrichment 
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method is similar to that described by Wood in 1965 which utilized an infusion broth base 
combined with antimicrobials to suppress and improve isolation rates (Wood, 1965).  This 
technique was originally described for isolation of Erysipelothrix spp. from contaminated and 
environmental samples.  The study reported in Chapter 3 of the dissertation describes a 
method closely resembling Wood’s method; however, was applied to all types of tissue 
specimens, not just contaminated or environmental samples.  Additional modifications were 
made to the protocol including the addition of a gram-positive selective agar (CNA) which 
allowed for a shorter period of incubation compared to the Erysipelothrix selective media.  
Samples from experimentally and naturally infected swine were subjected to both direct 
primary and enrichment culture.  Results indicated that a significant improvement was seen 
when enrichment culture was utilized (Bender et al., 2009).  Based on the results of this 
study the broth-based enrichment protocol has now been employed by the Iowa State 
Veterinary Diagnostic Laboratory and several other diagnostic laboratories as a need was 
realized to provide an accurate diagnosis to submitting veterinarians.   
 With an improved diagnostic method in place, the ability to investigate cases of swine 
erysipelas became a reality.  Condemnations due to swine erysipelas identified at slaughter 
continue to cause economic losses to the swine industry.  Chapter 4 describes an 
investigation at a regional abattoir which confirmed the presence of Erysipelothrix spp. in 
condemned swine tissue specimens suspected of erysipelas and further characterized 
recovered isolates.  Results of this study indicated that 84.3% of pork carcasses condemned 
as “swine erysipelas” at a regional abattoir were correctly condemned.  Interestingly, the 
number one reason for condemnations at slaughter over the past ten years has been classified 
as “septicemia”.  Not known however are the number of condemnations is classified as 
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“septicemia” truly due to swine erysipelas, as several bacterial septicemic conditions 
manifest similarly.  For this reason the full economic impact of swine erysipelas to the 
United States pork industry may be underestimated.  This study also compared serotype 
distribution and lesion stage classification.  Previous reports have demonstrated an 
association between serotype and clinical manifestations of disease, with E. rhusiopathiae 
serotype 1a being associated with acute erysipelas, and E. rhusiopathiae serotype 2 being 
associated with subacute and chronic erysipelas (Imada et al., 2004; Takahashi et al., 1996; 
Wood, 1999).  In contrast, in the current study both serotypes 1a and 2 were identified in all 
three stages; however, were still the most common serotypes identified.  An additional 
finding was the presence of E. tonsillarum serotypes 7 and 10 in two cases of condemned 
chronic erysipelas.  Previous literature reported E. tonsillarum to be of minimal etiologic 
significance for swine and E. tonsillarum has even been suggested to be non-pathogenic for 
swine (Takahashi et al., 1987).  These findings suggest that the full impact of E. tonsillarum 
strains may be underestimated and should be further investigated.  Finally, isolates recovered 
in this study were characterized utilizing a multiplex real-time PCR assay capable of 
differentiating between differnt spa types.  All E. rhusiopathiae isolates collected were found 
to be positive for spaA, while all E. tonsillarum isolates were found to be negative for known 
spa types.  A limiting factor in this study was the inability to trace condemned carcasses back 
to the farm of origin to confirm previous swine erysipelas infections or vaccination usage.  
The identification of spa types associated with erysipelas condemnations should be further 
investigated as more advanced molecular tools are being utilized to classify and study 
potential vaccine candidates. 
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 The study in Chapter 5 identified and further characterized Erysipelothrix spp. 
isolates from tissues of clinically affected pigs and associated environments from acute 
erysipelas outbreaks in vaccinated pigs in six Midwest U.S. swine operations.  Few reports 
have investigated the association between tissue and environmental isolates from swine 
affected with erysipelas.  Published reports that are available have mainly dealt with 
environmental samples from swine sites without clinically affected pigs (Cysewski et al., 
1978; Wood, 1973; Wood, 1974; Wood and Packer, 1972).  This study demonstrated that 
Erysipelothrix spp. could be isolated from swine tissues and associated environments; 
however, the serotypes identified in tissues or environmental serotypes were found to be 
variable on 2 of 6 sites.  In addition, one site yielded no environmental isolates except that of 
oral fluids.  These findings possibly suggest the pig as being the most important reservoir for 
maintaining erysipelas infections rather than the environment as Erysipelothrix has been 
shown to have a rapid death curve (Wood, 1973).  This study was also the first to report Spa 
types present in isolates obtained from clinical outbreaks as previous studies have utilized 
reference strains.  All E. rhusiopathiae isolates obtained in this study were positive for a 
single Spa type, spaA.  Attenuated-live vaccine strains were utilized at 4 of 6 sites, and all 
were found to be positive for spaA.  Based on previous cross protection studies, pigs should 
be protected against homologous strains by a vaccine containing a similar Spa type.  In this 
study the pigs were not protected; however, additional factors such as vaccine handling and 
administration must not be overlooked.  This work agrees with previous reports that Spa-
types are likely quite conserved amongst the swine population; however, further 
investigations utilizing more sites should be conducted.  Further characterization of 
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environmental isolates led to the identification of a novel Erysipelothrix species currently 
classified as E. species strain 3.    
 This work can be summarized in three main points:  First, a broth based enrichment 
technique must be utilized to increase Erysipelothrix spp. isolation success and to obtain 
isolates for further characterization.  Second, swine continue to be condemned for erysipelas 
at slaughter and the associated serotypes continue to be the same.  Finally the associations of 
Erysipelothrix present in tissue samples and the environment is variable. Vaccine candidates 
based on Spa-type may protect under controlled conditions; however, further studies under 
field conditions should be conducted to further support this.   
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